<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Ketogenic diet,Acetoacetate,Acetoacetic acid,Acetone,Acidosis,Alzheimer’s disease,American Medical Association,American cheese,Amyotrophic lateral sclerosis,Animal model,Anticonvulsant" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Ketogenic_diet&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Ketogenic_diet&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Ketogenic diet - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Ketogenic_diet";
		var wgTitle = "Ketogenic diet";
		var wgAction = "view";
		var wgArticleId = "791546";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281856233;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Ketogenic_diet skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Ketogenic diet</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<div class="dablink">This article is about a dietary medical therapy.  For information on ketogenic low-carbohydrate diets as a lifestyle choice or for <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a>, see <a href="/wiki/Low-carbohydrate_diet" title="Low-carbohydrate diet">Low-carbohydrate diet</a>.</div>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Ketonuria.jpg" class="image" title="Testing for ketone bodies in urine"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/1/18/Ketonuria.jpg/180px-Ketonuria.jpg" width="180" height="180" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Ketonuria.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Testing for <a href="/wiki/Ketonuria" title="Ketonuria">ketone bodies in urine</a></div>
</div>
</div>
<p>The <b>ketogenic diet</b> is a high fat, adequate <a href="/wiki/Protein" title="Protein">protein</a>, <a href="/wiki/Low-carbohydrate_diet" title="Low-carbohydrate diet">low carbohydrate diet</a>, primarily used to treat difficult-to-control (refractory) <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a> in children. The diet mimics aspects of <a href="/wiki/Starvation" title="Starvation">starvation</a> by forcing the body to burn fat rather than <a href="/wiki/Carbohydrate" title="Carbohydrate">carbohydrate</a>. Normally, the carbohydrates in food are converted into glucose, which is then transported around the body and is particularly important in fuelling the brain. However, if there is very little carbohydrate in the diet, the <a href="/wiki/Liver" title="Liver">liver</a> converts <a href="/wiki/Triacylglycerol" title="Triacylglycerol" class="mw-redirect">fat</a> into <a href="/wiki/Fatty_acid" title="Fatty acid">fatty acids</a> and <a href="/wiki/Ketone_bodies" title="Ketone bodies">ketone bodies</a>. The ketone bodies pass into the brain and replace glucose as an energy source. When the body produces ketone bodies—a state known as <a href="/wiki/Ketosis" title="Ketosis">ketosis</a>—this has an <a href="/wiki/Anticonvulsant" title="Anticonvulsant">anticonvulsant</a> effect.<sup id="cite_ref-Freeman2007_0-0" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>The diet has just enough protein for body growth and repair, and sufficient <a href="/wiki/Calorie" title="Calorie">calories</a> to maintain the correct weight for age and height. The "classic" ketogenic diet contains a 4:1 ratio by weight of fat to combined protein and carbohydrate. This is achieved by eliminating foods high in carbohydrates (starchy fruits and vegetables, bread, pasta, grains and sugar) while increasing the consumption of foods high in fat (cream and butter).<sup id="cite_ref-Freeman2007_0-1" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>Most dietary fat contains long-chain triglycerides (LCT), but a form of <a href="/wiki/Coconut_oil" title="Coconut oil">coconut oil</a> can be manufactured that contains only <a href="/wiki/Medium_chain_triglycerides" title="Medium chain triglycerides">medium-chain triglycerides</a> (MCT), which are much more ketogenic.<sup id="cite_ref-Freeman2007_0-2" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup> A variant of the diet known as the MCT ketogenic diet uses MCT oil to provide between 30 and 60% of the calories. Carbohydrates and protein can be increased a little, which allows for greater freedom in planning meals.<sup id="cite_ref-MatthewsFriends1_1-0" class="reference"><a href="#cite_note-MatthewsFriends1-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<p>Developed in the 1920s, the ketogenic diet's popularity waned with the introduction of effective <a href="/wiki/Anticonvulsant" title="Anticonvulsant">anticonvulsant</a> drugs. In the mid 1990s the Hollywood producer <a href="/wiki/Jim_Abrahams" title="Jim Abrahams">Jim Abrahams</a>, whose son's severe epilepsy was effectively controlled by the diet, created the Charlie Foundation to promote it. Publicity included an appearance on NBC's <a href="/wiki/Dateline_NBC" title="Dateline NBC">Dateline</a> programme and <i><a href="/wiki/%E2%80%A6First_Do_No_Harm" title="…First Do No Harm">…First Do No Harm</a></i> (1997), a TV movie starring <a href="/wiki/Meryl_Streep" title="Meryl Streep">Meryl Streep</a>. The foundation sponsored a multicentre research study and the results, which were published in 1996, marked the beginning of renewed scientific interest in the diet.<sup id="cite_ref-Freeman2007_0-3" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup> The potential use of the diet as a treatment for medical conditions other than epilepsy is, as of 2008, still at the research stage.<sup id="cite_ref-Kossoff2008b_2-0" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p>In 2008, a <a href="/wiki/Randomised_controlled_trial" title="Randomised controlled trial" class="mw-redirect">randomised controlled trial</a> showed a clear benefit for treating refractory epilepsy in children.<sup id="cite_ref-Neal2008_3-0" class="reference"><a href="#cite_note-Neal2008-3" title=""><span>[</span>4<span>]</span></a></sup> This added weight to conclusions drawn from the many earlier uncontrolled trials of the ketogenic diet's efficacy and safety, which already provided sufficient evidence to recommend clinical use. In children with refractory epilepsy, the ketogenic diet is more likely to be effective than trying an alternative anticonvulsant drug. There is some evidence that adults with epilepsy may benefit from the diet, and that a less strict regime, such as a modified <a href="/wiki/Atkins_diet" title="Atkins diet">Atkins</a>, could be effective.<sup id="cite_ref-Freeman2007_0-4" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Epilepsy"><span class="tocnumber">1</span> <span class="toctext">Epilepsy</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">2</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2"><a href="#Fasting"><span class="tocnumber">2.1</span> <span class="toctext">Fasting</span></a></li>
<li class="toclevel-2"><a href="#Diet"><span class="tocnumber">2.2</span> <span class="toctext">Diet</span></a></li>
<li class="toclevel-2"><a href="#Anticonvulsants"><span class="tocnumber">2.3</span> <span class="toctext">Anticonvulsants</span></a></li>
<li class="toclevel-2"><a href="#MCT_diet"><span class="tocnumber">2.4</span> <span class="toctext">MCT diet</span></a></li>
<li class="toclevel-2"><a href="#Revival"><span class="tocnumber">2.5</span> <span class="toctext">Revival</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Efficacy"><span class="tocnumber">3</span> <span class="toctext">Efficacy</span></a>
<ul>
<li class="toclevel-2"><a href="#Trial_design"><span class="tocnumber">3.1</span> <span class="toctext">Trial design</span></a></li>
<li class="toclevel-2"><a href="#Outcomes"><span class="tocnumber">3.2</span> <span class="toctext">Outcomes</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Indications_and_contra-indications"><span class="tocnumber">4</span> <span class="toctext">Indications and contra-indications</span></a></li>
<li class="toclevel-1"><a href="#Interactions"><span class="tocnumber">5</span> <span class="toctext">Interactions</span></a></li>
<li class="toclevel-1"><a href="#Adverse_effects"><span class="tocnumber">6</span> <span class="toctext">Adverse effects</span></a></li>
<li class="toclevel-1"><a href="#Initiation"><span class="tocnumber">7</span> <span class="toctext">Initiation</span></a></li>
<li class="toclevel-1"><a href="#Maintenance"><span class="tocnumber">8</span> <span class="toctext">Maintenance</span></a></li>
<li class="toclevel-1"><a href="#Discontinuation"><span class="tocnumber">9</span> <span class="toctext">Discontinuation</span></a></li>
<li class="toclevel-1"><a href="#Variants"><span class="tocnumber">10</span> <span class="toctext">Variants</span></a>
<ul>
<li class="toclevel-2"><a href="#Classic"><span class="tocnumber">10.1</span> <span class="toctext">Classic</span></a></li>
<li class="toclevel-2"><a href="#MCT_oil"><span class="tocnumber">10.2</span> <span class="toctext">MCT oil</span></a></li>
<li class="toclevel-2"><a href="#Modified_Atkins"><span class="tocnumber">10.3</span> <span class="toctext">Modified Atkins</span></a></li>
<li class="toclevel-2"><a href="#Low_glycemic_index_treatment"><span class="tocnumber">10.4</span> <span class="toctext">Low glycemic index treatment</span></a></li>
<li class="toclevel-2"><a href="#Prescribed_formulations"><span class="tocnumber">10.5</span> <span class="toctext">Prescribed formulations</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Mechanism_of_action"><span class="tocnumber">11</span> <span class="toctext">Mechanism of action</span></a>
<ul>
<li class="toclevel-2"><a href="#Seizure_pathology"><span class="tocnumber">11.1</span> <span class="toctext">Seizure pathology</span></a></li>
<li class="toclevel-2"><a href="#Seizure_control"><span class="tocnumber">11.2</span> <span class="toctext">Seizure control</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Other_applications"><span class="tocnumber">12</span> <span class="toctext">Other applications</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">13</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#Further_reading"><span class="tocnumber">14</span> <span class="toctext">Further reading</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">15</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Epilepsy" id="Epilepsy"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=1" title="Edit section: Epilepsy">edit</a>]</span> <span class="mw-headline">Epilepsy</span></h2>
<p><a href="/wiki/Epilepsy" title="Epilepsy">Epilepsy</a> is the second most common <a href="/wiki/Neurology" title="Neurology">neurological</a> disorder (after <a href="/wiki/Stroke" title="Stroke">stroke</a>) and is diagnosed in a person having recurrent unprovoked <a href="/wiki/Seizure" title="Seizure">seizures</a>. Epileptic seizures occur when <a href="/wiki/Cortex_(anatomy)" title="Cortex (anatomy)">cortical</a> <a href="/wiki/Neuron" title="Neuron">neurons</a> fire excessively and/or hypersynchronously, leading to temporary disruption of brain function. This may affect, for example, the muscles, the senses, the mind, or a combination. A seizure confined to one part of the brain is called a <a href="/wiki/Focal_seizure" title="Focal seizure" class="mw-redirect">focal seizure</a>, but if it occurs througout the brain it is a <a href="/wiki/Generalised_seizure" title="Generalised seizure" class="mw-redirect">generalised seizure</a>, which leads to a loss of consciousness. Epilepsy can occur for a variety of reasons and some forms have been classified into epileptic <a href="/wiki/Syndrome" title="Syndrome">syndromes</a>, most of which begin in childhood. Drugs that prevent or stop seizures are known as <a href="/wiki/Anticonvulsant" title="Anticonvulsant">anticonvulsants</a>. Epilepsy is considered refractory to treatment when two or three drugs have failed to control it. About 60% of patients will achieve control of their epilepsy with the first drug they use; about 30% do not achieve control with anticonvulsant drugs. Some of these patients may be candidates for epilepsy surgery.<sup id="cite_ref-Stafstrom2004_4-0" class="reference"><a href="#cite_note-Stafstrom2004-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=2" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>The ketogenic diet is a mainstream therapy that was developed to improve on the success and limitations of the non-mainstream use of <a href="/wiki/Fasting" title="Fasting">fasting</a> to treat <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a>. Although popular for a while, it was discarded when <a href="/wiki/Anticonvulsant" title="Anticonvulsant">anticonvulsant</a> drugs became available.<sup id="cite_ref-Freeman2007_0-5" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup> Most individuals with epilepsy can successfully control their seizures with medication. However, a stubborn 20–30% fail to achieve such control despite trying a number of different drugs.<sup id="cite_ref-Kossoff2008b_2-1" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup> For this group, and for children in particular, the diet has once again found a role in epilepsy management.<sup id="cite_ref-Freeman2007_0-6" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p><a name="Fasting" id="Fasting"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=3" title="Edit section: Fasting">edit</a>]</span> <span class="mw-headline">Fasting</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Conklin_Fasting_-_NewYorkTimes.png" class="image" title="A news report of Dr Hugh Conklin's &quot;water diet&quot; treatment from 1922"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/45/Conklin_Fasting_-_NewYorkTimes.png/180px-Conklin_Fasting_-_NewYorkTimes.png" width="180" height="229" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Conklin_Fasting_-_NewYorkTimes.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
A news report of Dr Hugh Conklin's "water diet" treatment from 1922</div>
</div>
</div>
<p>The ancient Greek physicians treated diseases, including epilepsy, by altering their patient's diet.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup> However, the treatment of <a href="/wiki/Seizure" title="Seizure">seizures</a> by fasting patients was not popular.<sup id="cite_ref-Wheless2004_6-0" class="reference"><a href="#cite_note-Wheless2004-6" title=""><span>[</span>7<span>]</span></a></sup> An early treatise concerning epilepsy, <i>On the Sacred Disease</i>, can be found in the <a href="/wiki/Hippocratic_Corpus" title="Hippocratic Corpus">Hippocratic Corpus</a> and dates from around 400&#160;BC. Its author argued against the prevailing view that epilepsy was supernatural in origin and cure, and proposed that dietary therapy had a rational and physical basis.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup> In the same collection, the author of <i>Epidemics</i> describes the case of a man whose epilepsy is cured as quickly as it had appeared, through complete abstinence of food and drink.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup> The royal physician, <a href="/wiki/Erasistratus" title="Erasistratus">Erasistratus</a>, declared, "One inclining to epilepsy should be made to fast without mercy and be put on short rations."<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup> <a href="/wiki/Galen" title="Galen">Galen</a> believed an "attenuating diet" might afford a cure in mild cases and be helpful in others.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup></p>
<p>The first modern study of fasting as a treatment for epilepsy was in France in 1911.<sup id="cite_ref-Guelpa1911_11-0" class="reference"><a href="#cite_note-Guelpa1911-11" title=""><span>[</span>12<span>]</span></a></sup> Twenty patients, of all ages, were "detoxified" by consuming a low-calorie vegetarian diet, combined with periods of fasting and purging. A couple of patients benefited enormously, but most failed to maintain compliance with the imposed restrictions. The diet improved the patients' mental capabilities, in contrast to their medication, <a href="/wiki/Potassium_bromide" title="Potassium bromide">potassium bromide</a>, which dulled the mind.<sup id="cite_ref-Bailey2005_12-0" class="reference"><a href="#cite_note-Bailey2005-12" title=""><span>[</span>13<span>]</span></a></sup></p>
<p>Around this time, the American exponent of <a href="/wiki/Physical_culture" title="Physical culture">physical culture</a>, <a href="/wiki/Bernarr_Macfadden" title="Bernarr Macfadden">Bernarr Macfadden</a>, popularised the use of fasting to restore health. His disciple, the <a href="/wiki/Osteopathic_medicine_in_the_United_States" title="Osteopathic medicine in the United States">osteopathic physician</a> Hugh Conklin, of <a href="/wiki/Battle_Creek,_Michigan" title="Battle Creek, Michigan">Battle Creek, Michigan</a>, began to treat his epilepsy patients by fasting them. Conklin conjectured that epileptic seizures were caused when a toxin, secreted from the <a href="/wiki/Peyer%27s_patches" title="Peyer's patches">Peyer's patches</a> in the intestines, was discharged into the bloodstream. He recommended a fast lasting 18 to 25&#160;days to allow this toxin to dissipate. Conklin probably treated hundreds of epilepsy patients with his "water diet" and boasted of a 90% cure rate in children (a rate that declined with patient age). Later analysis of Conklin's records show 20% achieved freedom from seizures and 50% had some improvement.<sup id="cite_ref-Wheless2004_6-1" class="reference"><a href="#cite_note-Wheless2004-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p>Conklin's fasting therapy was adopted by <a href="/wiki/Neurology" title="Neurology">neurologists</a> in mainstream practice. In 1916, a Dr. McMurray wrote to the <i><a href="/w/index.php?title=New_York_Medical_Journal&amp;action=edit&amp;redlink=1" class="new" title="New York Medical Journal (page does not exist)">New York Medical Journal</a></i> claiming to have successfully treated epilepsy patients, since 1912, with a fast followed by a starch- and sugar-free diet. In 1921, prominent <a href="/wiki/Endocrinology" title="Endocrinology">endocrinologist</a> H. Rawle Geyelin reported his experiences to the <a href="/wiki/American_Medical_Association" title="American Medical Association">American Medical Association</a> convention. He had seen Conklin's success first-hand and had attempted to reproduce the results in 36 of his own patients. He got similar results, but had only studied the patients over a short period. Further studies in the 1920s indicated that seizures generally returned after the fast. Charles Howland, the parent of one of Conklin's successful patients and a wealthy New York corporate lawyer, gave his brother John a gift of $5,000 to study "the ketosis of starvation". As professor of paediatrics at <a href="/wiki/Johns_Hopkins_Hospital" title="Johns Hopkins Hospital">Johns Hopkins Hospital</a>, John Howland used the money to fund research undertaken by neurologist <a href="/wiki/Stanley_Cobb" title="Stanley Cobb">Stanley Cobb</a> and his assistant <a href="/wiki/William_G._Lennox" title="William G. Lennox" class="mw-redirect">William G. Lennox</a>.<sup id="cite_ref-Wheless2004_6-2" class="reference"><a href="#cite_note-Wheless2004-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p><a name="Diet" id="Diet"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=4" title="Edit section: Diet">edit</a>]</span> <span class="mw-headline">Diet</span></h3>
<p>In 1921, Rollin Woodyatt reviewed the research on diet and <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetes</a>. He reported that three water-soluble compounds, <a href="/wiki/Beta-Hydroxybutyric_acid" title="Beta-Hydroxybutyric acid">β-hydroxybutyrate</a>, <a href="/wiki/Acetoacetate" title="Acetoacetate" class="mw-redirect">acetoacetate</a> and <a href="/wiki/Acetone" title="Acetone">acetone</a> (known as <a href="/wiki/Ketone_bodies" title="Ketone bodies">ketone bodies</a>) were produced by the liver in otherwise healthy people when they were starved or if they consumed a diet that is too low in carbohydrate and too high in fat. Russel Wilder, at the <a href="/wiki/Mayo_Clinic" title="Mayo Clinic">Mayo Clinic</a>, built on this research and coined the term <i>ketogenic diet</i> to describe a diet that produced a high level of ketones in the blood (<a href="/wiki/Ketonemia" title="Ketonemia">ketonemia</a>) through an excess of fat and lack of carbohydrate. Wilder hoped to obtain the benefits of fasting in a dietary therapy that could be maintained indefinitely. His trial, in 1921, on a few epilepsy patients was the first use of the ketogenic diet as a treatment for epilepsy.<sup id="cite_ref-Wheless2004_6-3" class="reference"><a href="#cite_note-Wheless2004-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p>Wilder's colleague, paediatrician Mynie Peterman, later formulated the "classic" diet, with a ratio of one gram of protein per kg of body weight in children, 10–15&#160;g of carbohydrate per day, and the remainder of calories from fat. Peterman's work, in the 1920s, established the techniques for induction and maintenance of the diet, and documented both positive and negative side effects. During this period, the <a href="/wiki/Massachusetts_General_Hospital" title="Massachusetts General Hospital">Massachusetts General Hospital</a>, under Fritz Talbot, established their ketogenic diet programme, which was very similar to the current one at Johns Hopkins Hospital. Talbot proposed that the ideal therapeutic ratio of fat to combined protein and carbohydrate was 4:1. He was the first to monitor the level of excess ketone production (<a href="/wiki/Ketosis" title="Ketosis">ketosis</a>) by <a href="/wiki/Urinalysis" title="Urinalysis">measuring</a> the amount excreted in the urine (<a href="/wiki/Ketonuria" title="Ketonuria">ketonuria</a>).<sup id="cite_ref-Wheless2004_6-4" class="reference"><a href="#cite_note-Wheless2004-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p><a name="Anticonvulsants" id="Anticonvulsants"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=5" title="Edit section: Anticonvulsants">edit</a>]</span> <span class="mw-headline">Anticonvulsants</span></h3>
<p>During the 1920s and 1930s, when the only anticonvulsant drugs were the sedative <a href="/wiki/Potassium_bromide" title="Potassium bromide">bromides</a> (discovered 1857) and <a href="/wiki/Phenobarbital" title="Phenobarbital">phenobarbital</a> (1912), the ketogenic diet was widely used and studied. This changed in 1938 when <a href="/wiki/H._Houston_Merritt" title="H. Houston Merritt">H. Houston Merritt</a> and Tracy Putnam discovered <a href="/wiki/Phenytoin" title="Phenytoin">phenytoin</a> (Dilantin), and the focus of research shifted to discovering new drugs. With the introduction of <a href="/wiki/Sodium_valproate" title="Sodium valproate">sodium valproate</a> in the 1970s, neurologists had drugs that were effective across a broad range of epileptic syndromes and seizure types. The use of the ketogenic diet, already restricted to difficult cases such as <a href="/wiki/Lennox-Gastaut_syndrome" title="Lennox-Gastaut syndrome">Lennox-Gastaut syndrome</a>, declined further.<sup id="cite_ref-Wheless2004_6-5" class="reference"><a href="#cite_note-Wheless2004-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p><a name="MCT_diet" id="MCT_diet"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=6" title="Edit section: MCT diet">edit</a>]</span> <span class="mw-headline">MCT diet</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Liquigen.jpg" class="image" title="Medium-chain triglyceride (MCT) oil emulsion"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/9/95/Liquigen.jpg/180px-Liquigen.jpg" width="180" height="270" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Liquigen.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<a href="/wiki/Medium_chain_triglycerides" title="Medium chain triglycerides">Medium-chain triglyceride</a> (MCT) oil emulsion</div>
</div>
</div>
<p>In the 1960s, it was discovered that <a href="/wiki/Medium_chain_triglycerides" title="Medium chain triglycerides">medium-chain triglycerides</a> (MCTs) are much more ketogenic than normal dietary fats (which are mostly long-chain triglycerides). This is because MCTs are absorbed rapidly and contain many calories. The classic ketogenic diet's severe carbohydrate restrictions made it difficult for parents to produce palatable meals and few could maintain it for long. In 1971, Peter Huttenlocher devised a ketogenic diet where about 60% of the calories came from the MCT oil, and this allowed more protein and up to three times as much carbohydrate as the classic ketogenic diet. The oil was mixed with at least twice its volume of skimmed milk, chilled, and sipped during the meal or incorporated into food. He tested it on a dozen children and adolescents with intractable seizures. Most children improved in both seizure control and alertness: results that were similar to the classic ketogenic diet. Gastrointestinal side effects were a problem, which led one patient to abandon the diet, but meals were easier to prepare and better accepted by the children.<sup id="cite_ref-Huttenlocher1971_13-0" class="reference"><a href="#cite_note-Huttenlocher1971-13" title=""><span>[</span>14<span>]</span></a></sup> The MCT diet replaced the classic ketogenic diet in many hospitals, though some devised diets that were a combination of the two.<sup id="cite_ref-Wheless2004_6-6" class="reference"><a href="#cite_note-Wheless2004-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p><a name="Revival" id="Revival"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=7" title="Edit section: Revival">edit</a>]</span> <span class="mw-headline">Revival</span></h3>
<p>The ketogenic diet achieved national media exposure in October 1994, when NBC's <a href="/wiki/Dateline_NBC" title="Dateline NBC">Dateline</a> television programme reported the case of Charlie Abrahams, son of Hollywood producer <a href="/wiki/Jim_Abrahams" title="Jim Abrahams">Jim Abrahams</a>. The two-year-old suffered badly from epilepsy that had remained undefeated by mainstream and alternative therapies. Abrahams discovered a reference to the ketogenic diet in an epilepsy guide for parents and brought Charlie to the Johns Hopkins Hospital, which was one of the few institutions still offering the therapy. Under the diet, Charlie's epilepsy was rapidly controlled and his developmental progress resumed. This inspired Abrahams to create the Charlie Foundation to promote the diet and fund research.<sup id="cite_ref-Wheless2004_6-7" class="reference"><a href="#cite_note-Wheless2004-6" title=""><span>[</span>7<span>]</span></a></sup> A multicentre prospective study began in 1994 and was presented to the American Epilepsy Society in 1996. There followed an explosion of scientific interest in the diet. In 1997, Abrahams produced a TV movie, <i><a href="/wiki/%E2%80%A6First_Do_No_Harm" title="…First Do No Harm">…First Do No Harm</a></i>, starring <a href="/wiki/Meryl_Streep" title="Meryl Streep">Meryl Streep</a>, in which a young boy's intractable epilepsy is successfully treated by the ketogenic diet.<sup id="cite_ref-Freeman2007_0-7" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>As of 2007, the ketogenic diet is available from around 75 centres in 45 countries. The form of classic or MCT ketogenic diet offered varies with the hospital and culturally. Less restrictive variants, such as the modified <a href="/wiki/Atkins_diet" title="Atkins diet">Atkins diet</a>, have emerged as alternatives, particularly among older children and adults. The ketogenic diet is also under investigation for the treatment of a wide variety of disorders other than epilepsy.<sup id="cite_ref-Freeman2007_0-8" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p><a name="Efficacy" id="Efficacy"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=8" title="Edit section: Efficacy">edit</a>]</span> <span class="mw-headline">Efficacy</span></h2>
<p><a name="Trial_design" id="Trial_design"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=9" title="Edit section: Trial design">edit</a>]</span> <span class="mw-headline">Trial design</span></h3>
<p>Early studies reported high success rates for the diet: in one study in 1925, 60% of patients became <a href="/wiki/Seizure" title="Seizure">seizure</a> free, and another 35% benefited from a halving of their seizure frequency. These studies generally examined a <a href="/wiki/Cohort_study" title="Cohort study">cohort</a> of patients recently treated by the physician (known as retrospective studies), and selected patients who had successfully maintained the dietary restrictions. However, these studies are hard to compare to modern trials. One reason is that these older trials suffered from <a href="/wiki/Selection_bias" title="Selection bias">selection bias</a>, as they excluded patients who were unable to start or maintain the diet and thereby selected from patients who would generate better results.</p>
<p>Another difference between older and newer studies is that the type of patients treated with the ketogenic diet has changed over time. When first developed and used, the ketogenic diet was not a treatment of last resort; in contrast, the children in modern studies have already tried and failed a number of anticonvulsant drugs, so may be assumed to have more difficult-to-treat epilepsy. Modern study design prefers a prospective cohort (the patients in the study are chosen before therapy begins) and that results are presented for all patients irrespective of whether they started or completed the treatment (known as <a href="/wiki/Intention_to_treat_analysis" title="Intention to treat analysis">intent-to-treat analysis</a>). This is an attempt to control for selection bias. Early and modern studies also differ because the treatment <a href="/wiki/Protocol_(natural_sciences)" title="Protocol (natural sciences)">protocol</a> has changed. In older protocols, the diet was initiated with a prolonged <a href="/wiki/Fasting" title="Fasting">fast</a>, designed to lose 5–10% <a href="/wiki/Body_weight" title="Body weight">body weight</a>, this heavily restricted the calorie intake. Concerns over child health and growth led to a relaxation of the diet's restrictions.<sup id="cite_ref-Hartman2007b_14-0" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup></p>
<p><a name="Outcomes" id="Outcomes"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=10" title="Edit section: Outcomes">edit</a>]</span> <span class="mw-headline">Outcomes</span></h3>
<p>The effect of the diet is gauged by noting any change in the frequency of seizures, rather than a laboratory measurement of ketone levels or analysis of <a href="/wiki/Electroencephalogram" title="Electroencephalogram" class="mw-redirect">electroencephalogram</a> (EEG) changes. There is no way to predict who will benefit from the diet, as there is no relationship between outcome and age, sex, principle seizure type or initial EEG. Adults can benefit too, though adherence to the regime becomes more difficult with adolescence. Fortunately, success at reducing seizures will motivate the patient and carers to persevere with the diet's rigours.<sup id="cite_ref-Hartman2007b_14-1" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup></p>
<p>Children with refractory epilepsy are more likely to find the ketogenic diet to be effective than trying an alternative anticonvulsant drug.<sup id="cite_ref-Freeman2007_0-9" class="reference"><a href="#cite_note-Freeman2007-0" title=""><span>[</span>1<span>]</span></a></sup> For patients who benefit, half will achieve a seizure reduction within five days (if the diet starts with an initial fast of one to two days), three-quarters achieve a reduction within a fortnight and 90% achieve a reduction within 23 days. If the diet does not begin with a fast, the time for half of the patients to achieve an improvement is longer (a fortnight) but the long-term seizure reduction rates are unaffected. Since fasting increases the risk of <a href="/wiki/Metabolic_acidosis" title="Metabolic acidosis">acidosis</a> and <a href="/wiki/Hypoglycaemia" title="Hypoglycaemia" class="mw-redirect">hypoglycaemia</a>, its use is particularly beneficial where there is some medical urgency. If no improvement is seen within two months, it is likely that the diet has failed.<sup id="cite_ref-Kossoff2008_15-0" class="reference"><a href="#cite_note-Kossoff2008-15" title=""><span>[</span>16<span>]</span></a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:322px;"><a href="/wiki/File:Ketogenic_diet_over_12_months.png" class="image" title="Efficacy of the ketogenic diet at 3, 6 and 12 months, showing the percentage of children in each outcome category. From a prospective study of 150 children treated at Johns Hopkins Hospital.[17]"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/6/64/Ketogenic_diet_over_12_months.png/320px-Ketogenic_diet_over_12_months.png" width="320" height="305" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Ketogenic_diet_over_12_months.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Efficacy of the ketogenic diet at 3, 6 and 12 months, showing the percentage of children in each outcome category. From a prospective study of 150 children treated at Johns Hopkins Hospital.<sup id="cite_ref-Freeman1998_16-0" class="reference"><a href="#cite_note-Freeman1998-16" title=""><span>[</span>17<span>]</span></a></sup></div>
</div>
</div>
<p>The biggest modern study with an intent-to-treat prospective design was published in 1998.<sup id="cite_ref-Freeman1998_16-1" class="reference"><a href="#cite_note-Freeman1998-16" title=""><span>[</span>17<span>]</span></a></sup> As with most studies of the ketogenic diet, there was no control group (patients who were denied the treatment). A team from the <a href="/wiki/Johns_Hopkins_Hospital" title="Johns Hopkins Hospital">Johns Hopkins Hospital</a> studied 150 children for at least 12 months. By three months, 25 patients had dropped out, 26% had a good reduction in seizures (50–90% reduction), 31% had an excellent reduction (90–99% reduction) and 3% became seizure free. By twelve months, 67 patients had dropped out, 23% had a good reduction, 20% had an excellent reduction and 7% were seizure free. In the same year, a multicentre study of 51 children<sup id="cite_ref-Vining1998_17-0" class="reference"><a href="#cite_note-Vining1998-17" title=""><span>[</span>18<span>]</span></a></sup> showed similar efficacy, and proved that the results could be repeated by other institutions.<sup id="cite_ref-Hartman2007b_14-2" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup></p>
<p>It is possible to combine the results of a number of small studies to produce evidence that is stronger than available from each study alone. This statistical method is known as <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> and it was performed on the ketogenic diet by the <a href="/wiki/Blue_Cross_and_Blue_Shield_Association" title="Blue Cross and Blue Shield Association">Blue Cross and Blue Shield Association</a> in 2000.<sup id="cite_ref-Lefevre2000_18-0" class="reference"><a href="#cite_note-Lefevre2000-18" title=""><span>[</span>19<span>]</span></a></sup> It confirmed that about half the children starting the diet will achieve at least a 50% reduction in seizure frequency. About half drop out by twelve months and these are patients who had less than 50% reduction.<sup id="cite_ref-Hartman2007b_14-3" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup></p>
<p>In 2003, a <a href="/wiki/Cochrane_Collaboration" title="Cochrane Collaboration">Cochrane</a> <a href="/wiki/Systematic_review" title="Systematic review">review</a> of the published literature found there were no <a href="/wiki/Randomised_controlled_trial" title="Randomised controlled trial" class="mw-redirect">randomised controlled trials</a> on the ketogenic diet. Such trials randomly allocate the studied patients into two groups: those that receive the treatment and those that do not. This allows the groups to be compared and is particularly important for medical conditions where patients often get better without treatment. The review concluded that there was "no reliable evidence from randomised controlled trials to support the use of ketogenic diets for people with epilepsy" and stated that the diet was merely "a possible option" in the treatment of intractable epilepsy.<sup id="cite_ref-Cochrane_19-0" class="reference"><a href="#cite_note-Cochrane-19" title=""><span>[</span>20<span>]</span></a></sup></p>
<p>Long-term <a href="/wiki/Blind_experiment" title="Blind experiment">blinding</a> (where participants are unaware if they are receiving the treatment a <a href="/wiki/Placebo" title="Placebo">placebo</a> instead) is made difficult by the nature of the diet. However, a short-term blinded study is possible, by secretly introducing glucose into the diet of some patients, which spoils the effect of the diet. Children would be randomised to receive a drink that contained glucose or one containing an <a href="/wiki/Artificial_sweetener" title="Artificial sweetener" class="mw-redirect">artificial sweetener</a>.<sup id="cite_ref-Hartman2007b_14-4" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup> A long-term randomised placebo-controlled trial is not considered feasible. It may also be unethical since it would require physicians to withhold an effective treatment (meta-analysis of the many uncontrolled prospective and retrospective trials already provides sufficient evidence to recommend clinical use).<sup id="cite_ref-Henderson2006_20-0" class="reference"><a href="#cite_note-Henderson2006-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<p>The first randomised controlled trial was published in 2008, which had an intent-to-treat prospective design, but no blinding. It studied 145 children, half of whom started the ketogenic diet immediately, and half after a three-month delay. Of the children in the diet group, 38% had at least a 50% reduction in seizure frequency, 7% had at least a 90% reduction; one child became seizure-free. Only 6% of the control group saw a greater than 50% reduction in seizure frequency and no children had a 90% reduction. The <a href="/wiki/Arithmetic_mean" title="Arithmetic mean">mean</a> seizure frequency of the diet group fell by a third; the control group's mean seizure frequency actually got worse.<sup id="cite_ref-Neal2008_3-1" class="reference"><a href="#cite_note-Neal2008-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p><a name="Indications_and_contra-indications" id="Indications_and_contra-indications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=11" title="Edit section: Indications and contra-indications">edit</a>]</span> <span class="mw-headline">Indications and contra-indications</span></h2>
<p>The ketogenic diet is indicated as an adjunctive (additional) treatment in children with drug-resistant epilepsy.<sup id="cite_ref-NICE_21-0" class="reference"><a href="#cite_note-NICE-21" title=""><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-Cochrane_19-1" class="reference"><a href="#cite_note-Cochrane-19" title=""><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-SIGN_22-0" class="reference"><a href="#cite_note-SIGN-22" title=""><span>[</span>23<span>]</span></a></sup> The ketogenic diet is endorsed by national <a href="/wiki/Medical_guideline" title="Medical guideline">guidelines</a> in Scotland,<sup id="cite_ref-SIGN_22-1" class="reference"><a href="#cite_note-SIGN-22" title=""><span>[</span>23<span>]</span></a></sup> England and Wales<sup id="cite_ref-NICE_21-1" class="reference"><a href="#cite_note-NICE-21" title=""><span>[</span>22<span>]</span></a></sup> and by US insurance companies.<sup id="cite_ref-Lefevre2000_18-1" class="reference"><a href="#cite_note-Lefevre2000-18" title=""><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-UniCare_23-0" class="reference"><a href="#cite_note-UniCare-23" title=""><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-BlueCross_24-0" class="reference"><a href="#cite_note-BlueCross-24" title=""><span>[</span>25<span>]</span></a></sup> In the UK, the <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence">National Institute for Health and Clinical Excellence</a> states that the diet should not be recommended for adults with epilepsy because there is insufficient evidence of efficacy.<sup id="cite_ref-NICE_21-2" class="reference"><a href="#cite_note-NICE-21" title=""><span>[</span>22<span>]</span></a></sup> The diet is probably less likely to be successful in children with very <a href="/wiki/Focal_epilepsy" title="Focal epilepsy">focal epilepsy</a> (where a single well-defined part of the brain is responsible for the seizures), who are candidates for surgery.<sup id="cite_ref-Kossoff2008b_2-2" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p>Advocates for the diet recommend it be seriously considered after two medications have failed, as the chance of other drugs succeeding is only 10%.<sup id="cite_ref-Kossoff2008b_2-3" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-Kossoff2004_25-0" class="reference"><a href="#cite_note-Kossoff2004-25" title=""><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-Spendiff2008_26-0" class="reference"><a href="#cite_note-Spendiff2008-26" title=""><span>[</span>27<span>]</span></a></sup> The diet could be considered earlier for some epilepsy and genetic syndromes where it has shown particular usefulness. These include <a href="/wiki/Dravet_syndrome" title="Dravet syndrome" class="mw-redirect">Dravet syndrome</a>, <a href="/wiki/Infantile_spasms" title="Infantile spasms" class="mw-redirect">infantile spasms</a>, <a href="/wiki/Myoclonic-astatic_epilepsy" title="Myoclonic-astatic epilepsy" class="mw-redirect">myoclonic-astatic epilepsy</a> and <a href="/wiki/Tuberous_sclerosis_complex" title="Tuberous sclerosis complex" class="mw-redirect">tuberous sclerosis complex</a>.<sup id="cite_ref-Kossoff2008b_2-4" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p>A survey in 2005 of 88 paediatric neurologists in the US found that 36% regularly prescribed the diet after three or more drugs had failed; 24% occasionally prescribed the diet as a last resort; 24% had only prescribed the diet in a few rare cases; and 16% had never prescribed the diet. There are several possible explanations for this gap between the <a href="/wiki/Evidence-based_medicine" title="Evidence-based medicine">evidence</a> and clinical practice.<sup id="cite_ref-Mastriani2008_27-0" class="reference"><a href="#cite_note-Mastriani2008-27" title=""><span>[</span>28<span>]</span></a></sup> One major factor may be the lack of adequately trained <a href="/wiki/Dietitian" title="Dietitian">dietitians</a>, who are needed to operate a ketogenic diet programme.<sup id="cite_ref-Kossoff2004_25-1" class="reference"><a href="#cite_note-Kossoff2004-25" title=""><span>[</span>26<span>]</span></a></sup></p>
<p>Because the ketogenic diet radically alters the metabolic state of the body, it is a <a href="/wiki/First-line_therapy" title="First-line therapy" class="mw-redirect">first-line therapy</a> in children with certain <a href="/wiki/Congenital_metabolic_disease" title="Congenital metabolic disease" class="mw-redirect">congenital metabolic diseases</a>, but in others, it is an absolutely <a href="/wiki/Contraindication" title="Contraindication">contraindicated</a>. The diseases, <a href="/wiki/Pyruvate_dehydrogenase_deficiency" title="Pyruvate dehydrogenase deficiency">pyruvate dehydrogenase (E1) deficiency</a> and <a href="/wiki/De_Vivo_disease" title="De Vivo disease">glucose transporter 1 deficiency syndrome</a> prevent the body from using carbohydrate as fuel, which leads to a dependency on ketone bodies. The ketogenic diet is beneficial in treating the seizures and some other symptoms in those diseases.<sup id="cite_ref-Huffman2006_28-0" class="reference"><a href="#cite_note-Huffman2006-28" title=""><span>[</span>29<span>]</span></a></sup> In contrast, the diseases <a href="/wiki/Pyruvate_carboxylase_deficiency" title="Pyruvate carboxylase deficiency">pyruvate carboxylase deficiency</a>, <a href="/wiki/Porphyria" title="Porphyria">porphyria</a> and various rare <a href="/wiki/Inborn_errors_of_lipid_metabolism" title="Inborn errors of lipid metabolism" class="mw-redirect">genetic disorders of fat metabolism</a> prevent any use of the diet.<sup id="cite_ref-Kossoff2008b_2-5" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p><a name="Interactions" id="Interactions"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=12" title="Edit section: Interactions">edit</a>]</span> <span class="mw-headline">Interactions</span></h2>
<p>The ketogenic diet is usually initiated in combination with the patient's existing drug regime, though these may be discontinued if the diet is successful. Despite concomittant medication being the norm, there is little data on drug interactions. No anticonvulsant drugs have been found to be beneficial or harmful when used in combination with the ketogenic diet. There is some evidence of synergystic benefits when the ketogenic diet and the <a href="/wiki/Vagus_nerve_stimulation" title="Vagus nerve stimulation">vagus nerve stimulator</a> are used together.<sup id="cite_ref-Kossoff2008b_2-6" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p><a name="Adverse_effects" id="Adverse_effects"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=13" title="Edit section: Adverse effects">edit</a>]</span> <span class="mw-headline">Adverse effects</span></h2>
<p>The ketogenic diet is not a benign holistic or natural treatment for epilepsy; as with any serious medical therapy, there may be complications. These are generally less severe and less frequent than with anticonvulsant medication or surgery.<sup id="cite_ref-Turner2006_29-0" class="reference"><a href="#cite_note-Turner2006-29" title=""><span>[</span>30<span>]</span></a></sup> Common but easily treatable side effects include <a href="/wiki/Constipation" title="Constipation">constipation</a>, lack of appropriate weight gain for age, low-grade <a href="/wiki/Acidosis" title="Acidosis">acidosis</a>, and <a href="/wiki/Hypoglycaemia" title="Hypoglycaemia" class="mw-redirect">hypoglycaemia</a> if there is an initial fast. <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">Cholesterol may increase</a> by around 30%.<sup id="cite_ref-Turner2006_29-1" class="reference"><a href="#cite_note-Turner2006-29" title=""><span>[</span>30<span>]</span></a></sup></p>
<p>About 1 in 20 children on the ketogenic diet will develop <a href="/wiki/Kidney_stone" title="Kidney stone">kidney stones</a> (compared with 1 in several thousand for the general population). A class of anticonvulsants known as <a href="/wiki/Carbonic_anhydrase_inhibitors" title="Carbonic anhydrase inhibitors" class="mw-redirect">carbonic anhydrase inhibitors</a> (<a href="/wiki/Topiramate" title="Topiramate">topiramate</a>, <a href="/wiki/Zonisamide" title="Zonisamide">zonisamide</a>) are known to increase the risk of kidney stones, but the combination of these anticonvulsants and the ketogenic diet does not appear to elevate that risk.<sup id="cite_ref-Sampath2007_30-0" class="reference"><a href="#cite_note-Sampath2007-30" title=""><span>[</span>31<span>]</span></a></sup> The stones are treatable and do not lead to discontinuation of the diet. Oral <a href="/wiki/Potassium_citrate" title="Potassium citrate">potassium citrate</a> is preventative and has no clear disadvantages; its routine use is under investigation.<sup id="cite_ref-Sampath2007_30-1" class="reference"><a href="#cite_note-Sampath2007-30" title=""><span>[</span>31<span>]</span></a></sup> Kidney stone formation (nephrolithiasis) occurs on the diet for four reasons.<sup id="cite_ref-Sampath2007_30-2" class="reference"><a href="#cite_note-Sampath2007-30" title=""><span>[</span>31<span>]</span></a></sup></p>
<ul>
<li>Excess calcium in the urine (<a href="/wiki/Hypercalciuria" title="Hypercalciuria">hypercalciuria</a>) occurs due to increased bone demineralisation with <a href="/wiki/Metabolic_acidosis" title="Metabolic acidosis">acidosis</a> (bone phosphate acts as an acid buffer) as well as increased calcium excretion by the kidney.</li>
<li>There is an abnormally low concentration of citrate in the urine (hypocitraturia), which normally helps to dissolve free calcium.</li>
<li>The urine has a low pH, which stops <a href="/wiki/Uric_acid" title="Uric acid">uric acid</a> from dissolving, leading to crystals that act as a nidus for calcium stone formation.</li>
<li>Many institutions restrict fluids on the diet to 80% of normal daily needs.</li>
</ul>
<p><a name="Initiation" id="Initiation"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=14" title="Edit section: Initiation">edit</a>]</span> <span class="mw-headline">Initiation</span></h2>
<p>The <a href="/wiki/Johns_Hopkins_Hospital" title="Johns Hopkins Hospital">Johns Hopkins Hospital</a> protocol for initiating the ketogenic diet has been widely adopted.<sup id="cite_ref-Kim2008_31-0" class="reference"><a href="#cite_note-Kim2008-31" title=""><span>[</span>32<span>]</span></a></sup> It involves a consultation with the patient and their carers, and, later, a short hospital admission.<sup id="cite_ref-Hartman2007b_14-5" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup> Johns Hopkins begins the diet with a short fast, which occasionally poses a significant health risk in young children, so a stay in hospital is necessary to monitor for complications.<sup id="cite_ref-Bergqvist2005_32-0" class="reference"><a href="#cite_note-Bergqvist2005-32" title=""><span>[</span>33<span>]</span></a></sup></p>
<p>At initial consultation, patients are <a href="/wiki/Screening_(medicine)" title="Screening (medicine)">screened</a> for conditions that may <a href="/wiki/Contraindicate" title="Contraindicate" class="mw-redirect">contraindicate</a> the diet. Dietary <a href="/wiki/Medical_history" title="Medical history">history</a> is obtained and the parameters of the diet selected: the ketogenic ratio, the calorie requirements, and the fluid intake.<sup id="cite_ref-Hartman2007b_14-6" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup></p>
<p>The day before admission to hospital, the level of carbohydrates in the diet is decreased and the patient begins fasting after their evening meal. On admission, only fluids are allowed until dinner, which consists of "<a href="/wiki/Eggnog" title="Eggnog">eggnog</a>" restricted to one-third of the usual calories for a meal. The following breakfast and lunch are similar, and on the second day, the dinner is increased to "eggnog" with two-thirds of the usual calories. By the third day, dinner contains the full calorie quota and is a standard ketogenic meal (not "eggnog"). After a ketogenic breakfast on the fourth day, the patient is discharged. If possible, the patient's current medicines are exchanged for carbohydrate-free formulations.<sup id="cite_ref-Hartman2007b_14-7" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup></p>
<p>When in the hospital, <a href="/wiki/Blood_sugar" title="Blood sugar">glucose levels</a> are checked and the patient is monitored for signs of symptomatic <a href="/wiki/Ketosis" title="Ketosis">ketosis</a> (which can be treated with a small quantity of orange juice). Lack of energy and lethargy are common but disappear within two weeks.<sup id="cite_ref-Vining1998_17-1" class="reference"><a href="#cite_note-Vining1998-17" title=""><span>[</span>18<span>]</span></a></sup> The parents attend classes over the first three full days, which cover nutrition, managing the diet, preparing meals, avoiding sugar and handling illness.<sup id="cite_ref-Hartman2007b_14-8" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup> The level of parental education and commitment required is much higher than with medication.<sup id="cite_ref-Kossoff2008_15-1" class="reference"><a href="#cite_note-Kossoff2008-15" title=""><span>[</span>16<span>]</span></a></sup></p>
<p>Variations on the Johns Hopkins protocol are common. If there is no initial fast, the time to reach ketosis is longer (but still achieved within five days), and there are fewer initial complications. The initiation can be performed using <a href="/wiki/Outpatient" title="Outpatient" class="mw-redirect">outpatient</a> clinics rather than requiring a stay in hospital. Fluid restriction may be relaxed, leading to fewer cases of <a href="/wiki/Dehydration" title="Dehydration">dehydration</a>. Rather than increasing meal sizes over the three-day initiation, some institutions maintain meal size but alter the ketogenic ratio from 2:1 to 4:1.<sup id="cite_ref-Hartman2007b_14-9" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup></p>
<p><a name="Maintenance" id="Maintenance"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=15" title="Edit section: Maintenance">edit</a>]</span> <span class="mw-headline">Maintenance</span></h2>
<p>At Johns Hopkins Hospital, outpatient clinics are held at 3, 6, 12, 18 and 24 months after initiation. A period of fine tuning is necessary to ensure consistent ketosis is maintained and better adapt the meal plans to the patient. This is typically done over the telephone with the hospital <a href="/wiki/Dietitian" title="Dietitian">dietitian</a>. <a href="/wiki/Ketonuria" title="Ketonuria">Urinary ketone levels</a> are checked daily to detect ketosis has been achieved, and confirm the patient is following the diet, but the level of ketones does not correlate with an anticonvulsant effect.<sup id="cite_ref-Hartman2007b_14-10" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup> The test strip contains <a href="/wiki/Nitroprusside" title="Nitroprusside" class="mw-redirect">nitroprusside</a>, which turns from buff-pink to marroon in the presence of acetoacetate (one of the three ketone bodies).<sup id="cite_ref-Musa-Veloso20004_33-0" class="reference"><a href="#cite_note-Musa-Veloso20004-33" title=""><span>[</span>34<span>]</span></a></sup></p>
<p>A short-lived increase in seizure frequency may occur during illness or if <a href="/wiki/Ketone" title="Ketone">ketone</a> levels fluctuate. The diet may be modified if seizure frequency remains high, or the child is losing weight.<sup id="cite_ref-Hartman2007b_14-11" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup> Loss of seizure-control may come from unexpected sources. Even "sugar-free" food can contain carbohydrates such as maltodextrin, sorbitol, starch and fructose. The sorbitol content of suntan lotion and other skincare products may be high enough for some to be absorbed enough through the skin, and negate ketosis.<sup id="cite_ref-Kossoff2004_25-2" class="reference"><a href="#cite_note-Kossoff2004-25" title=""><span>[</span>26<span>]</span></a></sup></p>
<p><a name="Discontinuation" id="Discontinuation"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=16" title="Edit section: Discontinuation">edit</a>]</span> <span class="mw-headline">Discontinuation</span></h2>
<p>About 10% of children on the ketogenic diet achieve freedom from seizures, and many manage to reduce or discontinue anticonvulsant drugs. At around two years on the diet, or after six months of seizure freedom, the diet may be gradually discontinued over a two- to three-month period. This is done by lowering the ketogenic ratio until urinary ketosis is no longer detected, and then lifting all calorie restrictions. Children who discontinue after achieving seizure freedom have about a 20% risk of seizures returning. The length of time until recurrence is highly variable but averages two years.</p>
<p>This recurrence risk compares with 10% for resective surgery (where part of the brain is removed) and 30–50% for anticonvulsant therapy. Of those that have a recurrence, just over half can regain freedom from seizures either with anticonvulsants, or by returning to the ketogenic diet. Recurrence is more likely if, despite seizure freedom, an EEG shows epileptiform spikes. These spikes are an indication of epileptic activity in the brain, but are below the level that will cause a seizure. Recurrence is also likely if an MRI shows focal abnormalities (for example, children with <a href="/wiki/Tuberous_sclerosis" title="Tuberous sclerosis">tuberous sclerosis</a>). Such children may remain on the diet longer than normal, and it has been suggested that children with tuberous sclerosis who achieve seizure freedom could remain on the ketogenic diet indefinitely.<sup id="cite_ref-Martinez2007_34-0" class="reference"><a href="#cite_note-Martinez2007-34" title=""><span>[</span>35<span>]</span></a></sup></p>
<p><a name="Variants" id="Variants"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=17" title="Edit section: Variants">edit</a>]</span> <span class="mw-headline">Variants</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Ketogenic_diets_pie.svg" class="image" title="The ratio of calorific contributions from food components of four diets"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Ketogenic_diets_pie.svg/180px-Ketogenic_diets_pie.svg.png" width="180" height="389" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Ketogenic_diets_pie.svg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
The ratio of calorific contributions from food components of four diets</div>
</div>
</div>
<p><a name="Classic" id="Classic"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=18" title="Edit section: Classic">edit</a>]</span> <span class="mw-headline">Classic</span></h3>
<p>The ketogenic diet is calculated by a <a href="/wiki/Dietitian" title="Dietitian">dietitian</a> for each child; age, weight, activity levels, culture and food preferences all affect the meal plan. First, the energy requirements are set at 80–90% of the recommended daily amounts (RDA) for the child's age (the high-fat diet requires less energy to process than a typical high-carbohydrate diet). Highly active children or those with muscle <a href="/wiki/Spasticity" title="Spasticity">spasticity</a> require more calories than this; immobile children require less. The ketogenic ratio of the diet compares the weight of fat to the combined weight of carbohydrate and protein. This is typically 4:1, but children who are under 18 months, who are over 12 years, or who are obese may be started on a 3:1 ratio. Fat is energy-rich, with 9&#160;kcal/g compared to 4&#160;kcal/g for carbohydrate or protein, so portions on the ketogenic diet are smaller than normal. The quantity of fat in the diet can be calculated from the overall energy requirements and the chosen ketogenic ratio. Next, the protein levels are set to allow for growth and body maintenance, and are around 1&#160;g protein for each kg of body weight. Lastly, the amount of carbohydrate is set according to what allowance is left, while maintaining the chosen ratio. Any carbohydrate in medications or <a href="/wiki/Dietary_supplement" title="Dietary supplement">supplements</a> must be subtracted from this allowance. The total daily amount of fat, protein and carbohydrate is then evenly divided across the meals.<sup id="cite_ref-Zupec-Kania2004_35-0" class="reference"><a href="#cite_note-Zupec-Kania2004-35" title=""><span>[</span>36<span>]</span></a></sup></p>
<p>A computer program may be used to help generate meals, which have four components: <a href="/wiki/Cream" title="Cream">heavy whipping cream</a>, a protein-rich food (typically meat), a fruit or vegetable, and butter, vegetable oil or mayonnaise. Only fruit and vegetables that are low in carbohydrate are allowed, which eliminates bananas, potatoes, peas and corn. Suitable fruits are divided into two groups based on the amount of carbohydrate they contain. Vegetables are similarly divided into two groups. Foods within each of these four groups may be freely substituted to allow for variation without needing to recalculate portions sizes. For example, cooked broccoli, Brussels sprouts, cauliflower and green beans are all equivalent. Fresh, canned or frozen foods are equivalent but raw and cooked vegetables differ, and processed foods are an additional complication. Parents are required to be precise when measuring food quantities on an electronic <a href="/wiki/Weighing_scale" title="Weighing scale">scale</a> accurate to 1&#160;g.<sup id="cite_ref-Zupec-Kania2004_35-1" class="reference"><a href="#cite_note-Zupec-Kania2004-35" title=""><span>[</span>36<span>]</span></a></sup></p>
<p>The ketogenic diet is deficient in several vitamins and minerals, so sugar-free <a href="/wiki/Dietary_supplement" title="Dietary supplement">supplements</a> are prescribed. The child must eat the whole meal and cannot have extra portions; any snacks must be incorporated into the meal plan. A small amount of MCT oil may be used help with constipation or increase ketosis.<sup id="cite_ref-Zupec-Kania2004_35-2" class="reference"><a href="#cite_note-Zupec-Kania2004-35" title=""><span>[</span>36<span>]</span></a></sup> A typical day of food for a child on a 4:1 ratio, 1500 calorie ketogenic diet comprises:<sup id="cite_ref-Turner2006_29-2" class="reference"><a href="#cite_note-Turner2006-29" title=""><span>[</span>30<span>]</span></a></sup></p>
<ul>
<li><b>Breakfast</b>: egg with bacon</li>
</ul>
<dl>
<dd>28&#160;g egg, 11&#160;g bacon, 37&#160;g of 36% heavy whipping cream, 23&#160;g butter, 9&#160;g apple.</dd>
</dl>
<ul>
<li><b>Snack</b>: peanut butter ball</li>
</ul>
<dl>
<dd>6&#160;g peanut butter, 9&#160;g butter.</dd>
</dl>
<ul>
<li><b>Lunch</b>: tuna salad</li>
</ul>
<dl>
<dd>28&#160;g tuna fish, 30&#160;g mayonnaise, 10&#160;g celery, 36&#160;g of 36% heavy whipping cream and 15&#160;g lettuce.</dd>
</dl>
<ul>
<li><b>Snack</b>: keto yogurt</li>
</ul>
<dl>
<dd>18&#160;g of 36% heavy whipping cream, 17&#160;g sour cream, 4&#160;g strawberries and <a href="/wiki/Artificial_sweetener" title="Artificial sweetener" class="mw-redirect">artificial sweetener</a>.</dd>
</dl>
<ul>
<li><b>Dinner</b>: cheeseburger</li>
</ul>
<dl>
<dd>22&#160;g minced (ground) beef, 10&#160;g <a href="/wiki/American_cheese" title="American cheese">American cheese</a>, 26&#160;g butter, 38&#160;g cream, 10&#160;g lettuce and 11&#160;g green beans.</dd>
</dl>
<ul>
<li><b>Snack</b>: keto custard</li>
</ul>
<dl>
<dd>25&#160;g of 36% heavy whipping cream, 9&#160;g egg and pure vanilla flavouring.</dd>
</dl>
<p>Ketogenic "eggnog" is used during induction and is a drink with the required ketogenic ratio. For example, a 4:1 ratio eggnog would contain 60&#160;g of 36% heavy whipping cream, 25&#160;g egg, vanilla and <a href="/wiki/Saccharin" title="Saccharin">saccharin</a> flavour. This contains 245&#160;calories, 4&#160;g protein, 2&#160;g carbohydrate and 24&#160;g fat (24:6 = 4:1).<sup id="cite_ref-Vining1998_17-2" class="reference"><a href="#cite_note-Vining1998-17" title=""><span>[</span>18<span>]</span></a></sup></p>
<p><a name="MCT_oil" id="MCT_oil"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=19" title="Edit section: MCT oil">edit</a>]</span> <span class="mw-headline">MCT oil</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Measuring_Ketocal.jpg" class="image" title="Measuring KetoCal—a powdered formula for administering the classic ketogenic diet"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Measuring_Ketocal.jpg/180px-Measuring_Ketocal.jpg" width="180" height="240" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Measuring_Ketocal.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Measuring KetoCal—a powdered formula for administering the classic ketogenic diet</div>
</div>
</div>
<p>Normal dietary fat contains long-chain <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a> (LCT). <a href="/wiki/Medium_chain_triglycerides" title="Medium chain triglycerides">Medium-chain triglycerides</a> are more ketogenic than LCTs. Their use allows the fat content to be lowered and consequently enables greater protein and carbohydrate intake.<sup id="cite_ref-Hartman2007b_14-12" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup> The original MCT diet developed by Peter Huttenlocher in the 1970s derived 60% of the calories from MCT oil.<sup id="cite_ref-Huttenlocher1971_13-1" class="reference"><a href="#cite_note-Huttenlocher1971-13" title=""><span>[</span>14<span>]</span></a></sup> Consuming that level of MCT caused abdominal cramps, diarrhoea and vomiting in some children. The MCT diet was modified in the 1980s by Ruby Schwartz at the <a href="/wiki/Radcliffe_Infirmary" title="Radcliffe Infirmary">John Radcliff Infirmary</a>, with only 30% of the calories from MCT oil.<sup id="cite_ref-Kossoff2008b_2-7" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup> In a five-year trial starting in 2001, Elizabeth Neil at the <a href="/wiki/Great_Ormond_Street_Hospital" title="Great Ormond Street Hospital">Great Ormond Street Hospital</a>, compared children on the classical diet with children on an MCT variant that derived 45% of the calories from MCT oil.<sup id="cite_ref-Neal2008_3-2" class="reference"><a href="#cite_note-Neal2008-3" title=""><span>[</span>4<span>]</span></a></sup> This level is a balance between achieving good ketosis and minimising gastrointestinal complains. The classical and modifed MCT ketogenic diets are equally efficatious and differences in tolerability are not statistically significant.<sup id="cite_ref-Kossoff2008b_2-8" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p><a name="Modified_Atkins" id="Modified_Atkins"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=20" title="Edit section: Modified Atkins">edit</a>]</span> <span class="mw-headline">Modified Atkins</span></h3>
<p>A modified <a href="/wiki/Atkins_diet" title="Atkins diet">Atkins diet</a> has been shown, in small uncontrolled studies, to be effective in children and adults.<sup id="cite_ref-Kossoff2008b_2-9" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup> The diet consists of 60% fat, 30% protein and 10% carbohydrate by weight; calories are not restricted. Carbohydrate is limited to 10&#160;g per day for at least one month, and gradually increased to 10% if this limitation is not tolerated. Consistently strong ketosis is more difficult to achieve than on the ketogenic diet; patients with wildly fluctuating urinary ketones have unfavourable seizure outcomes. Achieving the balance of fat, protein and carbohydrate can be difficult; patients may consume the appetising protein (meat) and leave or vomit the fat. Older children and adolescents who refuse the ketogenic diet's restrictions may tolerate the modified Atkins diet.<sup id="cite_ref-Kang2007b_36-0" class="reference"><a href="#cite_note-Kang2007b-36" title=""><span>[</span>37<span>]</span></a></sup></p>
<p><a name="Low_glycemic_index_treatment" id="Low_glycemic_index_treatment"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=21" title="Edit section: Low glycemic index treatment">edit</a>]</span> <span class="mw-headline">Low glycemic index treatment</span></h3>
<p>The low glycemic index treatment (LGIT) is an attempt to achieve the stable <a href="/wiki/Blood_glucose" title="Blood glucose" class="mw-redirect">blood glucose</a> levels seen in children on the classic ketogenic diet, using a much less restrictive regime<sup id="cite_ref-Pfeifer2005_37-0" class="reference"><a href="#cite_note-Pfeifer2005-37" title=""><span>[</span>38<span>]</span></a></sup>. The hypothesis is that stable blood glucose may be one of the mechanisms of action involved in the ketogenic diet. The LGIT allows far more carbohydrate than either the classic ketogenic diet or the modified Atkins diet: approximately 40–60&#160;g per day. The types of carbohydrate consumed are restricted to those that have a <a href="/wiki/Glycemic_index" title="Glycemic index">glycemic index</a> lower than 50. The LGIT, as with the modifed Atkins diet, has not been studied in large or randomised trials. Despite this, both are offered at most centres that run ketogenic diet programmes, and in some centres they are the primary dietary therapy choice for adolescents.<sup id="cite_ref-Kossoff2008b_2-10" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p><a name="Prescribed_formulations" id="Prescribed_formulations"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=22" title="Edit section: Prescribed formulations">edit</a>]</span> <span class="mw-headline">Prescribed formulations</span></h3>
<p>Infants, or patients fed via a <a href="/wiki/Feeding_tube" title="Feeding tube">gastrostomy tube</a> can also be given a ketogenic diet. Parents make up a <a href="/wiki/Medical_prescription" title="Medical prescription">prescribed</a> powdered formula, such as KetoCal, into a liquid feed.<sup id="cite_ref-Hartman2007b_14-13" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup> Gastrostomy feeding avoids any issues with palatability, and bottle-fed infants readily accept the ketogenic formula.<sup id="cite_ref-Kossoff2004_25-3" class="reference"><a href="#cite_note-Kossoff2004-25" title=""><span>[</span>26<span>]</span></a></sup> KetoCal is a <a href="/wiki/Enteral_formula" title="Enteral formula">nutritionally complete feed</a> containing milk protein and supplemented with amino acids, fat, carbohydrate, vitamins, minerals and trace elements. It is used to administer the 4:1 ratio classical ketogenic diet in children over one year. Each 100&#160;g of powder contains 73&#160;g fat, 15&#160;g protein and 3&#160;g carbohydrate, and is typically diluted 1:5 with water. The formula is available unflavoured or in an artificially sweetened vanilla flavour and is suitable for tube or sip feeding.<sup id="cite_ref-SHSketoCal_38-0" class="reference"><a href="#cite_note-SHSketoCal-38" title=""><span>[</span>39<span>]</span></a></sup></p>
<p><a name="Mechanism_of_action" id="Mechanism_of_action"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=23" title="Edit section: Mechanism of action">edit</a>]</span> <span class="mw-headline">Mechanism of action</span></h2>
<table class="gallery" cellspacing="0" cellpadding="0" align="right">
<caption><a href="/wiki/Ketone_bodies" title="Ketone bodies">Ketone bodies</a></caption>
<tr>
<td>
<div class="gallerybox" style="width: 115px;">
<div class="thumb" style="padding: 5px 0; width: 110px;">
<div style="margin-left: auto; margin-right: auto; width: 80px;"><a href="/wiki/File:Beta-hydroxybutyrate.png" class="image" title="Beta-hydroxybutyrate.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/4f/Beta-hydroxybutyrate.png/80px-Beta-hydroxybutyrate.png" width="80" height="54" border="0" /></a></div>
</div>
<div class="gallerytext">
<p><a href="/wiki/Beta-Hydroxybutyric_acid" title="Beta-Hydroxybutyric acid">β-hydroxybutyrate</a></p>
</div>
</div>
</td>
</tr>
<tr>
<td>
<div class="gallerybox" style="width: 115px;">
<div class="thumb" style="padding: 13px 0; width: 110px;">
<div style="margin-left: auto; margin-right: auto; width: 80px;"><a href="/wiki/File:Acetoacetic_acid.png" class="image" title="Acetoacetic acid.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/d/d4/Acetoacetic_acid.png/80px-Acetoacetic_acid.png" width="80" height="38" border="0" /></a></div>
</div>
<div class="gallerytext">
<p><a href="/wiki/Acetoacetic_acid" title="Acetoacetic acid">acetoacetic acid</a></p>
</div>
</div>
</td>
</tr>
<tr>
<td>
<div class="gallerybox" style="width: 115px;">
<div class="thumb" style="padding: 4px 0; width: 110px;">
<div style="margin-left: auto; margin-right: auto; width: 80px;"><a href="/wiki/File:Acetone.svg" class="image" title="Acetone.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Acetone.svg/54px-Acetone.svg.png" width="54" height="55" border="0" /></a></div>
</div>
<div class="gallerytext">
<p><a href="/wiki/Acetone" title="Acetone">acetone</a></p>
</div>
</div>
</td>
</tr>
</table>
<p><a name="Seizure_pathology" id="Seizure_pathology"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=24" title="Edit section: Seizure pathology">edit</a>]</span> <span class="mw-headline">Seizure pathology</span></h3>
<p>The brain is composed of a network of <a href="/wiki/Neurotransmission" title="Neurotransmission">neurons that transmit signals</a> by propagating <a href="/wiki/Nerve_impulse" title="Nerve impulse" class="mw-redirect">nerve impulses</a>. The propatation of this impulse from one neuron's <a href="/wiki/Chemical_synapse" title="Chemical synapse">synapse</a> to another is typically controlled by <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> chemicals, though there are also <a href="/wiki/Electrical_synapse" title="Electrical synapse">electrical pathways</a> between some neurons. Neurotransmitters can inhibit impulse firing (the most important of which is <a href="/wiki/Gamma-Aminobutyric_acid" title="Gamma-Aminobutyric acid">γ-aminobutyric acid</a> (GABA)) or they can excite the neuron into firing (the most important of which is <a href="/wiki/Glutamate" title="Glutamate" class="mw-redirect">glutamate</a>). A neuron that releases inhibitory neurotransmitters from its terminals is called an inhibitory neuron, and the opposite applies to excitatory neurons. When the normal balance between inhibition and excitation is significantly distrupted in part or all of the brain, a seizure can occur. The GABA system is an important target for anticonvulsant drugs since seizures may be discouraged by increasing GABA synthesis, decreasing its breakdown, or enhancing its effect on neurons.<sup id="cite_ref-Stafstrom2004_4-1" class="reference"><a href="#cite_note-Stafstrom2004-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>The nerve impulse is characterised by a great influx of sodium ions through <a href="/wiki/Voltage-gated_sodium_channel" title="Voltage-gated sodium channel" class="mw-redirect">channels</a> in the neuron's <a href="/wiki/Cell_membrane" title="Cell membrane">cell membrane</a> followed by a efflux of potassium ions through other <a href="/wiki/Voltage-gated_potassium_channel" title="Voltage-gated potassium channel">channels</a>. The neuron is unable fire again for a while (known as the refractory period), which is mediated by another <a href="/wiki/Calcium-activated_potassium_channel" title="Calcium-activated potassium channel">potassium channel</a>. The flow throw these <a href="/wiki/Ion_channel" title="Ion channel">ion channels</a> is goverened by a "gate" which is opened by either a <a href="/wiki/Voltage-gated_ion_channel" title="Voltage-gated ion channel">voltage change</a> or a <a href="/wiki/Ligand-gated_ion_channel" title="Ligand-gated ion channel">chemical messenger</a> known as as a <a href="/wiki/Ligand_(biochemistry)" title="Ligand (biochemistry)">ligand</a> (such as a neurotransmitter). These channels are another target for anticonvulsant drugs.<sup id="cite_ref-Stafstrom2004_4-2" class="reference"><a href="#cite_note-Stafstrom2004-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>During a seizure, the neuronal metabolism increases greatly.<sup id="cite_ref-Stafstrom2004_4-3" class="reference"><a href="#cite_note-Stafstrom2004-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>There is not one mechanism by which epilepsy occurs. Examples of pathological physiology include: unusual excitatory connections within the neuronal network of the brain; abnormal neuron structure leading to altered current flow; decreased inhibitory neurotransmitter synthesis; ineffective receptors for inhibitory neurotransmitters; insufficient breakdown of excitatory neurotransmitters leading to excess; immature synapse development; impaired function of ionic channels.<sup id="cite_ref-Stafstrom2004_4-4" class="reference"><a href="#cite_note-Stafstrom2004-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p><a name="Seizure_control" id="Seizure_control"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=25" title="Edit section: Seizure control">edit</a>]</span> <span class="mw-headline">Seizure control</span></h3>
<p>Many hypotheses have been put forward to explain how the ketogenic diet works; it remains a mystery. Disproven hypotheses include <a href="/wiki/Metabolic_acidosis" title="Metabolic acidosis">systemic acidosis</a>, <a href="/wiki/Electrolyte_disturbance" title="Electrolyte disturbance" class="mw-redirect">electrolyte changes</a> and <a href="/wiki/Hypoglycaemia" title="Hypoglycaemia" class="mw-redirect">hypoglycaemia</a>. Changes in <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> levels occur and cerebral energy state is improved.<sup id="cite_ref-Hartman2007b_14-14" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup> Although many biochemical changes are known to occur in the brain of a patient on the ketogenic diet, it is not known which of these has an anticonvulsant effect. The lack of understanding in this area is similar to the situation with anticonvulsant drugs.<sup id="cite_ref-Hartman2007_39-0" class="reference"><a href="#cite_note-Hartman2007-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p>On the ketogenic diet, carbohydrates are severely restricted and so cannot provide for all the metabolic needs of the body. Instead, fatty acids are used as the major source of fuel. These are used through <a href="/wiki/Fatty_acid_metabolism" title="Fatty acid metabolism">fatty-acid oxidation</a> in the <a href="/wiki/Mitochondria" title="Mitochondria" class="mw-redirect">mitochondria</a>. Humans can convert some amino acids into glucose by <a href="/wiki/Gluconeogenesis" title="Gluconeogenesis">gluconeogenesis</a>, but cannot do this for fatty acids.<sup id="cite_ref-Kerndt1982_40-0" class="reference"><a href="#cite_note-Kerndt1982-40" title=""><span>[</span>41<span>]</span></a></sup> Since amino acids are needed to make proteins, these cannot be used only to produce glucose. This poses a problem for the brain since it is normally fuelled solely by glucose, and fatty acids do not cross the <a href="/wiki/Blood-brain_barrier" title="Blood-brain barrier">blood-brain barrier</a>. To overcome this problem, the liver uses fatty acids to synthesise the three <a href="/wiki/Ketone_bodies" title="Ketone bodies">ketone bodies</a> <a href="/wiki/Beta-Hydroxybutyric_acid" title="Beta-Hydroxybutyric acid">β-hydroxybutyrate</a>, <a href="/wiki/Acetoacetate" title="Acetoacetate" class="mw-redirect">acetoacetate</a> and <a href="/wiki/Acetone" title="Acetone">acetone</a>. Ketone bodies can enter the brain and substitute for glucose.<sup id="cite_ref-Hartman2007_39-1" class="reference"><a href="#cite_note-Hartman2007-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p>The ketone bodies are possibly anticonvlusant in themselves; acetoacetate and acetone protect against seizures in <a href="/wiki/Animal_model" title="Animal model">animal models</a>. The ketogenic diet results in adaptive changes to brain energy metabolism that increases the energy reserves; ketone bodies are a more efficient fuel than glucose, and the number of mitochondria is increased. This may help the <a href="/wiki/Neuron" title="Neuron">neurons</a> to remain stable in the face of increased energy demand, and may confer a <a href="/wiki/Neuroprotective" title="Neuroprotective" class="mw-redirect">neuroprotective</a> effect.<sup id="cite_ref-Hartman2007_39-2" class="reference"><a href="#cite_note-Hartman2007-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p>The ketogenic diet has been studied in at least 14 rodent animal models of seizures. It is protective in many of these models and has a different protection profile than any known anticonvulsant. This, together with studies showing its efficacy in patients who have failed to achieve seizure control on half a dozen drugs, suggests a unique mechanism of action.<sup id="cite_ref-Hartman2007_39-3" class="reference"><a href="#cite_note-Hartman2007-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p>Anticonvulsants suppress epileptic seizures but they neither cure nor prevent the development of the inherent seizure susceptibility. The development of epilepsy (epileptogenesis) is a process that is poorly understood. A few anticonvulsants (<a href="/wiki/Valproate" title="Valproate" class="mw-redirect">valproate</a>, <a href="/wiki/Levetiracetam" title="Levetiracetam">levetiracetam</a> and <a href="/wiki/Benzodiazepine" title="Benzodiazepine">benzodiazepines</a>) have shown antiepileptogenic abilities in animal models of epileptogenesis. However, no anticonvulsant has ever achieved this in clinical trial in humans. The ketogenic diet has been found to have antiepileptogenic properties in rats.<sup id="cite_ref-Hartman2007_39-4" class="reference"><a href="#cite_note-Hartman2007-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p><a name="Other_applications" id="Other_applications"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=26" title="Edit section: Other applications">edit</a>]</span> <span class="mw-headline">Other applications</span></h2>
<p>A number of rare metabolic diseases may benefit directly from the ketogenic diet. Case reports on two children indicate a possible use in treating <a href="/wiki/Astrocytoma" title="Astrocytoma">astrocytomas</a>, which are a form of brain tumour. <a href="/wiki/Autism" title="Autism">Autism</a>, <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">depression</a>, <a href="/wiki/Migraine" title="Migraine">migraine</a> headaches, <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a>, and type 2 <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes mellitus</a> have been shown to benefit in small case studies. There is evidence from uncontrolled clinical trials and studies in animal models that the ketogenic diet can provide symptomatic and disease-modifying activity in a broad range of neurodegenerative disorders including <a href="/wiki/Amyotrophic_lateral_sclerosis" title="Amyotrophic lateral sclerosis">amyotrophic lateral sclerosis</a>, <a href="/wiki/Alzheimer%E2%80%99s_disease" title="Alzheimer’s disease" class="mw-redirect">Alzheimer’s disease</a> and <a href="/wiki/Parkinson%E2%80%99s_disease" title="Parkinson’s disease" class="mw-redirect">Parkinson’s disease</a>, and may be protective in <a href="/wiki/Traumatic_brain_injury" title="Traumatic brain injury">traumatic brain injury</a> and <a href="/wiki/Stroke" title="Stroke">stroke</a>.<sup id="cite_ref-Hartman2007b_14-15" class="reference"><a href="#cite_note-Hartman2007b-14" title=""><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-Gasior2006_41-0" class="reference"><a href="#cite_note-Gasior2006-41" title=""><span>[</span>42<span>]</span></a></sup><sup id="cite_ref-Baranano2008_42-0" class="reference"><a href="#cite_note-Baranano2008-42" title=""><span>[</span>43<span>]</span></a></sup> Because tumour cells are inefficient in processing ketone bodies for energy, the ketogenic diet has also been suggested for cancer.<sup id="cite_ref-Baranano2008_42-1" class="reference"><a href="#cite_note-Baranano2008-42" title=""><span>[</span>43<span>]</span></a></sup> As of 2008<sup class="plainlinks noprint asof-tag update" style="display:none;"><a href="http://en.wikipedia.org/w/index.php?title=Ketogenic_diet&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Ketogenic_diet&amp;action=edit" rel="nofollow">[update]</a></sup>, there is not sufficient evidence to support the use of the ketogenic diet as a treatment for these conditions.<sup id="cite_ref-Kossoff2008b_2-11" class="reference"><a href="#cite_note-Kossoff2008b-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=27" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-Freeman2007-0">^ <a href="#cite_ref-Freeman2007_0-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Freeman2007_0-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Freeman2007_0-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Freeman2007_0-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Freeman2007_0-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Freeman2007_0-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Freeman2007_0-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Freeman2007_0-7" title=""><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Freeman2007_0-8" title=""><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Freeman2007_0-9" title=""><sup><i><b>j</b></i></sup></a> Freeman JM, Kossoff EH, Hartman AL. <a href="http://pediatrics.aappublications.org/cgi/content/full/119/3/535" class="external text" title="http://pediatrics.aappublications.org/cgi/content/full/119/3/535" rel="nofollow">The ketogenic diet: one decade later.</a> <i>Pediatrics</i>. 2007 Mar;119(3):535–43. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17332207" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17332207">PMID 17332207</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1542%2Fpeds.2006-2447" class="external text" title="http://dx.doi.org/10.1542%2Fpeds.2006-2447" rel="nofollow">10.1542/peds.2006-2447</a>.</li>
<li id="cite_note-MatthewsFriends1-1"><b><a href="#cite_ref-MatthewsFriends1_1-0" title="">^</a></b> Neal EG, Chapple J, Magrath G. <a href="http://site.matthewsfriends.org/uploads/pdf/ClassicaMCTDiets.pdf" class="external text" title="http://site.matthewsfriends.org/uploads/pdf/ClassicaMCTDiets.pdf" rel="nofollow">Types of ketogenic diet.</a> (PDF). Matthews Friends. Updated 2 April 2007. Cited 18 April 2008.</li>
<li id="cite_note-Kossoff2008b-2">^ <a href="#cite_ref-Kossoff2008b_2-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-7" title=""><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-8" title=""><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-9" title=""><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-10" title=""><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Kossoff2008b_2-11" title=""><sup><i><b>l</b></i></sup></a> Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Bergqvist AG, Blackford R, <i>et al</i>. Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group. <i>Epilepsia</i>. 2008 Sep 23. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18823325" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18823325">PMID 18823325</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1111%2Fj.1528-1167.2008.01765.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1528-1167.2008.01765.x" rel="nofollow">10.1111/j.1528-1167.2008.01765.x</a>.</li>
<li id="cite_note-Neal2008-3">^ <a href="#cite_ref-Neal2008_3-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Neal2008_3-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Neal2008_3-2" title=""><sup><i><b>c</b></i></sup></a> Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, <i>et al</i>. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. <i>Lancet Neurol</i>. 2008 Jun;7(6):500–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18456557" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18456557">PMID 18456557</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1016%2FS1474-4422%2808%2970092-9" class="external text" title="http://dx.doi.org/10.1016%2FS1474-4422%2808%2970092-9" rel="nofollow">10.1016/S1474-4422(08)70092-9</a>.</li>
<li id="cite_note-Stafstrom2004-4">^ <a href="#cite_ref-Stafstrom2004_4-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Stafstrom2004_4-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Stafstrom2004_4-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Stafstrom2004_4-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Stafstrom2004_4-4" title=""><sup><i><b>e</b></i></sup></a> Stafstrom CE. An Introduction to Seizures and Epilepsy. In: Stafstrom CE, Rho JM, editors. <i>Epilepsy and the Ketogenic Diet</i>. Totowa: Humana Press; 2004. <a href="/wiki/Special:BookSources/1588292959" class="internal">ISBN 1588292959</a>.</li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> Temkin O. <i>The Falling Sickness: A History of Epilepsy from the Greeks to the Beginnings of Modern Neurology</i>. 2nd ed. Baltimore: Johns Hopkins University Press; 1971. p67–8. <a href="/wiki/Special:BookSources/0801848490" class="internal">ISBN 0-8018-4849-0</a>.</li>
<li id="cite_note-Wheless2004-6">^ <a href="#cite_ref-Wheless2004_6-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wheless2004_6-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Wheless2004_6-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Wheless2004_6-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Wheless2004_6-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Wheless2004_6-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Wheless2004_6-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Wheless2004_6-7" title=""><sup><i><b>h</b></i></sup></a> Wheless JW. <a href="http://www.springer.com/cda/content/document/cda_downloaddocument/9781588292599-c2.pdf?SGWID=0-0-45-396813-p173729498" class="external text" title="http://www.springer.com/cda/content/document/cda_downloaddocument/9781588292599-c2.pdf?SGWID=0-0-45-396813-p173729498" rel="nofollow">History and Origin of the Ketogenic Diet.</a> (PDF) In: Stafstrom CE, Rho JM, editors. <i>Epilepsy and the Ketogenic Diet</i>. Totowa: Humana Press; 2004. <a href="/wiki/Special:BookSources/1588292959" class="internal">ISBN 1588292959</a>.</li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> Hippocrates, <i><a href="http://en.wikisource.org/wiki/On_the_Sacred_Disease" class="extiw" title="s:On the Sacred Disease">On the Sacred Disease</a></i>, ch. 18; vol. 6. As cited by Temkin (1971), p66,78.</li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> Hippocrates, <i>Epidemics</i>, VII, 46; vol.5. As cited by Temkin (1971), p67</li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> Galen, <i>De venae sect. adv. Erasistrateos Romae degentes</i>; c. 8; vol. 11. As cited by Temkin (1971), p57</li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> Galen, <i>De victu attenuante</i>, c. 1. As cited by Temkin (1971), p71</li>
<li id="cite_note-Guelpa1911-11"><b><a href="#cite_ref-Guelpa1911_11-0" title="">^</a></b> Guelpa G, Marie A. La lutte contre l'epilepsie par la desintoxicatoin et par la reeducatoin alimentaire. Rev Ther med-Chirurg. 1911; 78: 8–13. As cited by Bailey (2005).</li>
<li id="cite_note-Bailey2005-12"><b><a href="#cite_ref-Bailey2005_12-0" title="">^</a></b> Bailey EE, Pfeifer HH, Thiele EA. The use of diet in the treatment of epilepsy. <i>Epilepsy Behav</i>. 2005 Feb;6(1):4–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15652725" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15652725">PMID 15652725</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1016%2Fj.yebeh.2004.10.006" class="external text" title="http://dx.doi.org/10.1016%2Fj.yebeh.2004.10.006" rel="nofollow">10.1016/j.yebeh.2004.10.006</a>.</li>
<li id="cite_note-Huttenlocher1971-13">^ <a href="#cite_ref-Huttenlocher1971_13-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Huttenlocher1971_13-1" title=""><sup><i><b>b</b></i></sup></a> Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. <i>Neurology</i>. 1971 Nov;21(11):1097–103. <a href="http://www.ncbi.nlm.nih.gov/pubmed/5166216" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/5166216">PMID 5166216</a></li>
<li id="cite_note-Hartman2007b-14">^ <a href="#cite_ref-Hartman2007b_14-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-7" title=""><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-8" title=""><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-9" title=""><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-10" title=""><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-11" title=""><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-12" title=""><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-13" title=""><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-14" title=""><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Hartman2007b_14-15" title=""><sup><i><b>p</b></i></sup></a> Hartman AL, Vining EP. <a href="http://www.blackwell-synergy.com/doi/full/10.1111/j.1528-1167.2007.00914.x" class="external text" title="http://www.blackwell-synergy.com/doi/full/10.1111/j.1528-1167.2007.00914.x" rel="nofollow">Clinical aspects of the ketogenic diet.</a> <i>Epilepsia</i>. 2007 Jan;48(1):31–42. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17241206" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17241206">PMID 17241206</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1111%2Fj.1528-1167.2007.00914.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1528-1167.2007.00914.x" rel="nofollow">10.1111/j.1528-1167.2007.00914.x</a></li>
<li id="cite_note-Kossoff2008-15">^ <a href="#cite_ref-Kossoff2008_15-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kossoff2008_15-1" title=""><sup><i><b>b</b></i></sup></a> Kossoff EH, Laux LC, Blackford R, Morrison PF, Pyzik PL, Hamdy RM, <i>et al</i>. <a href="http://site.matthewsfriends.org/uploads/File/TimeToImprovementKD.pdf" class="external text" title="http://site.matthewsfriends.org/uploads/File/TimeToImprovementKD.pdf" rel="nofollow">When do seizures usually improve with the ketogenic diet?</a> (PDF) <i>Epilepsia</i>. 2008 Feb;49(2):329–33. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18028405" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18028405">PMID 18028405</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1111%2Fj.1528-1167.2007.01417.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1528-1167.2007.01417.x" rel="nofollow">10.1111/j.1528-1167.2007.01417.x</a>.</li>
<li id="cite_note-Freeman1998-16">^ <a href="#cite_ref-Freeman1998_16-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Freeman1998_16-1" title=""><sup><i><b>b</b></i></sup></a> Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet–1998: a prospective evaluation of intervention in 150 children. <i>Pediatrics</i>. 1998 Dec;102(6):1358–63. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9832569" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9832569">PMID 9832569</a>. <a href="http://www.hopkinsmedicine.org/press/1998/DECEMBER/981207.HTM" class="external text" title="http://www.hopkinsmedicine.org/press/1998/DECEMBER/981207.HTM" rel="nofollow">Lay summary</a>—JHMI Office of Communications and Public Affairs. Updated 7 December 1998. Cited 6 March 2008.</li>
<li id="cite_note-Vining1998-17">^ <a href="#cite_ref-Vining1998_17-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Vining1998_17-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Vining1998_17-2" title=""><sup><i><b>c</b></i></sup></a> Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, Camfield PR, Holmes GL, <i>et al</i>. <a href="http://archneur.ama-assn.org/cgi/content/full/55/11/1433" class="external text" title="http://archneur.ama-assn.org/cgi/content/full/55/11/1433" rel="nofollow">A multicenter study of the efficacy of the ketogenic diet.</a> <i>Arch Neurol</i>. 1998 Nov;55(11):1433–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9823827" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9823827">PMID 9823827</a>.</li>
<li id="cite_note-Lefevre2000-18">^ <a href="#cite_ref-Lefevre2000_18-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lefevre2000_18-1" title=""><sup><i><b>b</b></i></sup></a> Lefevre F, Aronson N. <a href="http://pediatrics.aappublications.org/cgi/content/full/105/4/e46" class="external text" title="http://pediatrics.aappublications.org/cgi/content/full/105/4/e46" rel="nofollow">Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy.</a> <i>Pediatrics</i>. 2000 Apr;105(4):E46. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10742367" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10742367">PMID 10742367</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1542%2Fpeds.105.4.e46" class="external text" title="http://dx.doi.org/10.1542%2Fpeds.105.4.e46" rel="nofollow">10.1542/peds.105.4.e46</a>.</li>
<li id="cite_note-Cochrane-19">^ <a href="#cite_ref-Cochrane_19-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cochrane_19-1" title=""><sup><i><b>b</b></i></sup></a> Levy R, Cooper P. <a href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001903/frame.html" class="external text" title="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001903/frame.html" rel="nofollow">Ketogenic diet for epilepsy.</a> Cochrane Database Syst Rev. 2003;(3):CD001903. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12917915" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12917915">PMID 12917915</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1002%2F14651858.CD001903" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD001903" rel="nofollow">10.1002/14651858.CD001903</a></li>
<li id="cite_note-Henderson2006-20"><b><a href="#cite_ref-Henderson2006_20-0" title="">^</a></b> Henderson CB, Filloux FM, Alder SC, Lyon JL, Caplin DA. <a href="http://www.medscape.com/viewarticle/537227" class="external text" title="http://www.medscape.com/viewarticle/537227" rel="nofollow">Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis.</a> <i>J Child Neurol</i>. 2006 Mar;21(3):193–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16901419" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16901419">PMID 16901419</a>. (Free registration required.)</li>
<li id="cite_note-NICE-21">^ <a href="#cite_ref-NICE_21-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NICE_21-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NICE_21-2" title=""><sup><i><b>c</b></i></sup></a> National Collaborating Centre for Primary Care. <a href="http://guidance.nice.org.uk/CG20" class="external text" title="http://guidance.nice.org.uk/CG20" rel="nofollow">Clinical Guideline 20, The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care.</a> London: National Institute for Clinical Excellence; 2004. <a href="/wiki/Special:BookSources/1842578081" class="internal">ISBN 1-84257-808-1</a>.</li>
<li id="cite_note-SIGN-22">^ <a href="#cite_ref-SIGN_22-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-SIGN_22-1" title=""><sup><i><b>b</b></i></sup></a> Scottish Intercollegiate Guidelines Network. <a href="http://www.sign.ac.uk/pdf/sign81.pdf" class="external text" title="http://www.sign.ac.uk/pdf/sign81.pdf" rel="nofollow">Guideline 81, Diagnosis and management of epilepsies in children and young people. A national clinical guideline.</a> (PDF) Edinburgh (Scotland): Royal College of Physicians; 2005. <a href="/wiki/Special:BookSources/1899893245" class="internal">ISBN 1-899893-24-5</a>.</li>
<li id="cite_note-UniCare-23"><b><a href="#cite_ref-UniCare_23-0" title="">^</a></b> Unicare. <a href="http://medpolicy.unicare.com/policies/guidelines/MED/ketogenic_diet.html" class="external text" title="http://medpolicy.unicare.com/policies/guidelines/MED/ketogenic_diet.html" rel="nofollow">Clinicial Guideline CG-MED-05.</a> Updated 14 September 2006. Cited 28 December 2007.</li>
<li id="cite_note-BlueCross-24"><b><a href="#cite_ref-BlueCross_24-0" title="">^</a></b> Arkansas BlueCross BlueShield. <a href="http://www.arkansasbluecross.com/members/report.aspx?policyNumber=2004023" class="external text" title="http://www.arkansasbluecross.com/members/report.aspx?policyNumber=2004023" rel="nofollow">Ketogenic Diet as a Treatment for Refractory Epilepsy.</a> Updated November 2006. Cited 28 December 2007.</li>
<li id="cite_note-Kossoff2004-25">^ <a href="#cite_ref-Kossoff2004_25-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kossoff2004_25-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kossoff2004_25-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Kossoff2004_25-3" title=""><sup><i><b>d</b></i></sup></a> Kossoff EH, Freeman JM. The Ketogenic Diet—The Physician's Perspective. In: Stafstrom CE, Rho JM, editors. <i>Epilepsy and the Ketogenic Diet</i>. Totowa: Humana Press; 2004. p53–61 <a href="/wiki/Special:BookSources/1588292959" class="internal">ISBN 1588292959</a>.</li>
<li id="cite_note-Spendiff2008-26"><b><a href="#cite_ref-Spendiff2008_26-0" title="">^</a></b> Spendiff S. <a href="http://lifeandhealth.guardian.co.uk/wellbeing/story/0,,2273652,00.html" class="external text" title="http://lifeandhealth.guardian.co.uk/wellbeing/story/0,,2273652,00.html" rel="nofollow">The diet that can treat epilepsy.</a> <i>The Guardian</i>. 2008 Aug 15;Sect. Health &amp; wellbeing.</li>
<li id="cite_note-Mastriani2008-27"><b><a href="#cite_ref-Mastriani2008_27-0" title="">^</a></b> Mastriani KS, Williams VC, Hulsey TC, Wheless JW, Maria BL. Evidence-Based Versus Reported Epilepsy Management Practices. <i>J Child Neurol</i>. 2008 Feb 15; <a href="http://www.ncbi.nlm.nih.gov/pubmed/18281618" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18281618">PMID 18281618</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1177%2F0883073807309785" class="external text" title="http://dx.doi.org/10.1177%2F0883073807309785" rel="nofollow">10.1177/0883073807309785</a>.</li>
<li id="cite_note-Huffman2006-28"><b><a href="#cite_ref-Huffman2006_28-0" title="">^</a></b> Huffman J, Kossoff EH. <a href="http://www.matthewsfriends.org/jh/CurrentNNKossoff.pdf" class="external text" title="http://www.matthewsfriends.org/jh/CurrentNNKossoff.pdf" rel="nofollow">State of the ketogenic diet(s) in epilepsy</a> (PDF). <i>Curr Neurol Neurosci Rep</i>. 2006 Jul;6(4):332–40. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16822355" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16822355">PMID 16822355</a>.</li>
<li id="cite_note-Turner2006-29">^ <a href="#cite_ref-Turner2006_29-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Turner2006_29-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Turner2006_29-2" title=""><sup><i><b>c</b></i></sup></a> Turner Z, Kossoff EH. <a href="http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/TurnerArticle.pdf" class="external text" title="http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/TurnerArticle.pdf" rel="nofollow">The Ketogenic and Atkins Diets: Recipes for Seizure Control.</a> (PDF) <i>Practical Gastroenterology</i>. 2006. 29(6).</li>
<li id="cite_note-Sampath2007-30">^ <a href="#cite_ref-Sampath2007_30-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sampath2007_30-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sampath2007_30-2" title=""><sup><i><b>c</b></i></sup></a> Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP. <a href="http://site.matthewsfriends.org/uploads/File/StonesPolycitra1.pdf" class="external text" title="http://site.matthewsfriends.org/uploads/File/StonesPolycitra1.pdf" rel="nofollow">Kidney stones and the ketogenic diet: risk factors and prevention.</a> (PDF) <i>J Child Neurol</i>. 2007 Apr;22(4):375–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17621514" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17621514">PMID 17621514</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1177%2F0883073807301926" class="external text" title="http://dx.doi.org/10.1177%2F0883073807301926" rel="nofollow">10.1177/0883073807301926</a>.</li>
<li id="cite_note-Kim2008-31"><b><a href="#cite_ref-Kim2008_31-0" title="">^</a></b> Kim DY, Rho JM. The ketogenic diet and epilepsy. <i>Curr Opin Clin Nutr Metab Care</i>. 2008 Mar;11(2):113–120. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18301085" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18301085">PMID 18301085</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1097%2FMCO.0b013e3282f44c06" class="external text" title="http://dx.doi.org/10.1097%2FMCO.0b013e3282f44c06" rel="nofollow">10.1097/MCO.0b013e3282f44c06</a></li>
<li id="cite_note-Bergqvist2005-32"><b><a href="#cite_ref-Bergqvist2005_32-0" title="">^</a></b> Bergqvist AG, Schall JI, Gallagher PR, Cnaan A, Stallings VA. <a href="http://www.blackwell-synergy.com/doi/full/10.1111/j.1528-1167.2005.00282.x" class="external text" title="http://www.blackwell-synergy.com/doi/full/10.1111/j.1528-1167.2005.00282.x" rel="nofollow">Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy.</a> <i>Epilepsia</i>. 2005 Nov;46(11):1810–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16302862" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16302862">PMID 16302862</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1111%2Fj.1528-1167.2005.00282.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1528-1167.2005.00282.x" rel="nofollow">10.1111/j.1528-1167.2005.00282.x</a>.</li>
<li id="cite_note-Musa-Veloso20004-33"><b><a href="#cite_ref-Musa-Veloso20004_33-0" title="">^</a></b> Musa-Veloso K, Cunnane SC. Measuring and interpreting ketosis and fatty acid profiles in patients on a high-fat ketogenic diet. In: Stafstrom CE, Rho JM, editors. <i>Epilepsy and the Ketogenic Diet</i>. Totowa: Humana Press; 2004. p129–141 <a href="/wiki/Special:BookSources/1588292959" class="internal">ISBN 1588292959</a>.</li>
<li id="cite_note-Martinez2007-34"><b><a href="#cite_ref-Martinez2007_34-0" title="">^</a></b> Martinez CC, Pyzik PL, Kossoff EH. <a href="http://www.blackwell-synergy.com/doi/full/10.1111/j.1528-1167.2006.00911.x" class="external text" title="http://www.blackwell-synergy.com/doi/full/10.1111/j.1528-1167.2006.00911.x" rel="nofollow">Discontinuing the ketogenic diet in seizure-free children: recurrence and risk factors.</a> <i>Epilepsia</i>. 2007 Jan;48(1):187–90. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17241227" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17241227">PMID 17241227</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1111%2Fj.1528-1167.2006.00911.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1528-1167.2006.00911.x" rel="nofollow">10.1111/j.1528-1167.2006.00911.x</a>.</li>
<li id="cite_note-Zupec-Kania2004-35">^ <a href="#cite_ref-Zupec-Kania2004_35-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Zupec-Kania2004_35-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Zupec-Kania2004_35-2" title=""><sup><i><b>c</b></i></sup></a> Zupec-Kania B, Werner RR, Zupanc ML. Clinical Use of the Ketogenic Diet—The Dietitian's Role. In: Stafstrom CE, Rho JM, editors. <i>Epilepsy and the Ketogenic Diet</i>. Totowa: Humana Press; 2004. p53–61 <a href="/wiki/Special:BookSources/1588292959" class="internal">ISBN 1588292959</a>.</li>
<li id="cite_note-Kang2007b-36"><b><a href="#cite_ref-Kang2007b_36-0" title="">^</a></b> Kang HC, Lee HS, You SJ, Kang du C, Ko TS, Kim HD. <a href="http://www.blackwell-synergy.com/doi/full/10.1111/j.1528-1167.2006.00910.x" class="external text" title="http://www.blackwell-synergy.com/doi/full/10.1111/j.1528-1167.2006.00910.x" rel="nofollow">Use of a modified Atkins diet in intractable childhood epilepsy.</a> <i>Epilepsia</i>. 2007 Jan;48(1):182–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17241226" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17241226">PMID 17241226</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1111%2Fj.1528-1167.2006.00910.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1528-1167.2006.00910.x" rel="nofollow">10.1111/j.1528-1167.2006.00910.x</a>.</li>
<li id="cite_note-Pfeifer2005-37"><b><a href="#cite_ref-Pfeifer2005_37-0" title="">^</a></b> Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. <i>Neurology</i> 2005 Dec 13;65(11):1810-2. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16344529" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16344529">PMID 16344529</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1212%2F01.wnl.0000187071.24292.9e" class="external text" title="http://dx.doi.org/10.1212%2F01.wnl.0000187071.24292.9e" rel="nofollow">10.1212/01.wnl.0000187071.24292.9e</a>.</li>
<li id="cite_note-SHSketoCal-38"><b><a href="#cite_ref-SHSketoCal_38-0" title="">^</a></b> <a href="http://www.shs-nutrition.com/shs-product/ketocal/" class="external text" title="http://www.shs-nutrition.com/shs-product/ketocal/" rel="nofollow">KetoCal</a> SHS International. Updated 2007. Cited 7 March 2008.</li>
<li id="cite_note-Hartman2007-39">^ <a href="#cite_ref-Hartman2007_39-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hartman2007_39-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Hartman2007_39-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Hartman2007_39-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Hartman2007_39-4" title=""><sup><i><b>e</b></i></sup></a> Hartman AL, Gasior M, Vining EP, Rogawski MA. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=17509459" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=17509459" rel="nofollow">The neuropharmacology of the ketogenic diet.</a> <i>Pediatr Neurol</i>. 2007 May;36(5):281–292. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17509459" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17509459">PMID 17509459</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a href="http://dx.doi.org/10.1016%2Fj.pediatrneurol.2007.02.008" class="external text" title="http://dx.doi.org/10.1016%2Fj.pediatrneurol.2007.02.008" rel="nofollow">10.1016/j.pediatrneurol.2007.02.008</a>.</li>
<li id="cite_note-Kerndt1982-40"><b><a href="#cite_ref-Kerndt1982_40-0" title="">^</a></b> Kerndt PR, Naughton JL, Driscoll CE, Loxterkamp DA. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=6758355" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=6758355" rel="nofollow">Fasting: the history, pathophysiology and complications.</a> <i>West J Med</i>. 1982 Nov;137(5):379–99. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6758355" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/6758355">PMID 6758355</a>.</li>
<li id="cite_note-Gasior2006-41"><b><a href="#cite_ref-Gasior2006_41-0" title="">^</a></b> Gasior M, Rogawski MA, Hartman AL. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=16940764" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=16940764" rel="nofollow">Neuroprotective and disease-modifying effects of the ketogenic diet.</a> <i>Behav Pharmacol</i>. 2006;17(5–6):431–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16940764" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16940764">PMID 16940764</a>.</li>
<li id="cite_note-Baranano2008-42">^ <a href="#cite_ref-Baranano2008_42-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Baranano2008_42-1" title=""><sup><i><b>b</b></i></sup></a> Barañano KW, Hartman AL.The ketogenic diet: uses in epilepsy and other neurologic illnesses. <i>Curr Treat Options Neurol</i>. 2008;10(6):410-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18990309" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18990309">PMID 18990309</a>.</li>
</ol>
</div>
<p><a name="Further_reading" id="Further_reading"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=28" title="Edit section: Further reading">edit</a>]</span> <span class="mw-headline">Further reading</span></h2>
<ul>
<li>Freeman JM, Kossoff EH, Freeman JB, Kelly MT. <i>The Ketogenic Diet: A Treatment for Children and Others with Epilepsy</i>. 4th ed. New York: Demos; 2007. <a href="/wiki/Special:BookSources/1932603182" class="internal">ISBN 1932603182</a>.</li>
</ul>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Ketogenic_diet&amp;action=edit&amp;section=29" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://site.matthewsfriends.org/" class="external text" title="http://site.matthewsfriends.org/" rel="nofollow">Matthew's Friends.</a> A UK charity and information resource.</li>
<li><a href="http://www.charliefoundation.org/frames/index.php" class="external text" title="http://www.charliefoundation.org/frames/index.php" rel="nofollow">The Charlie Foundation.</a> A US charity and information resource, set up by <a href="/wiki/Jim_Abrahams" title="Jim Abrahams">Jim Abrahams</a>.</li>
<li><a href="http://www.hopkinsneuro.org/epilepsy/research.cfm?research=A_Talk_with_John_Freeman.htm" class="external text" title="http://www.hopkinsneuro.org/epilepsy/research.cfm?research=A_Talk_with_John_Freeman.htm" rel="nofollow">A Talk with John Freeman: Tending the Flame.</a> An interview discussing the ketogenic diet that appeared in BrainWaves, Fall 2003, Volume 16, Number 2.</li>
</ul>


<!-- 
NewPP limit report
Preprocessor node count: 1515/1000000
Post-expand include size: 5141/2048000 bytes
Template argument size: 1646/2048000 bytes
Expensive parser function count: 0/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:791546-0!1!0!default!!en!2 and timestamp 20090405073025 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Ketogenic_diet">http://en.wikipedia.org/wiki/Ketogenic_diet</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Diets" title="Category:Diets">Diets</a></span> | <span dir='ltr'><a href="/wiki/Category:Epilepsy" title="Category:Epilepsy">Epilepsy</a></span> | <span dir='ltr'><a href="/wiki/Category:Low-carb_diets" title="Category:Low-carb diets">Low-carb diets</a></span> | <span dir='ltr'><a href="/wiki/Category:High-fat_diets" title="Category:High-fat diets">High-fat diets</a></span> | <span dir='ltr'><a href="/wiki/Category:Medical_treatments" title="Category:Medical treatments">Medical treatments</a></span> | <span dir='ltr'><a href="/wiki/Category:Neurology" title="Category:Neurology">Neurology</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2008" title="Category:Articles containing potentially dated statements from 2008">Articles containing potentially dated statements from 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Ketogenic_diet" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Ketogenic_diet" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Ketogenic_diet&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Ketogenic_diet&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Ketogenic_diet" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Ketogenic_diet" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Ketogenic_diet" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Ketogenic_diet&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Ketogenic_diet&amp;oldid=281856233" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Ketogenic_diet&amp;id=281856233">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Ketogene_Di%C3%A4t">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Dieta_cetog%C3%A9nica">Español</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Di%C3%A8te_c%C3%A9tog%C3%A8ne">Français</a></li>
				<li class="interwiki-id"><a href="http://id.wikipedia.org/wiki/Diet_ketogenik">Bahasa Indonesia</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Ketogen_diet">Svenska</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 5 April 2009, at 07:29 (UTC).</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv154 in 0.060 secs. --></body></html>
